This bibliography shows the most interesting papers selected from pmc PubMedCentral which were newly included in covid028I
It is available online and for download at http://www.kidney.de/write/PMCmedVIP_covid028I.html
Skewed: Nephrology, Rheumatology, Immunology, Cell Biology, Research Methods. on-topic and educational Clinical Medicine.
The full table of all monthly collections is: at house-of-papers.com
PMC searches were done at moremed.org





{{tp|p=34116467|t=2021. Multisystem inflammatory syndrome in children with COVID-19.|pdf=|usr=}}
{{tp|p=34154831|t=2021. The comparison of oxidative markers between Covid-19 patients and healthy subjects.|pdf=|usr=}}
{{tp|p=34134920|t=2021. Vasoactive Peptides: Their Role in COVID-19 Pathogenesis and Potential Use as Biomarkers and Therapeutic Targets.|pdf=|usr=}}
{{tp|p=34118455|t=2021. Autoimmunity and COVID-19 - The microbiotal connection.|pdf=|usr=}}
{{tp|p=34116356|t=2021. Analysis of the molecular mechanism of SARS-CoV-2 antibodies.|pdf=|usr=}}
{{tp|p=34121839|t=2021. Bioinformatics Analysis Unveils Certain Mutations Implicated in Spike Structure Damage and Ligand-Binding Site of Severe Acute Respiratory Syndrome Coronavirus 2.|pdf=|usr=}}
{{tp|p=34153851|t=2021. Role of toll-like receptor 7/8 pathways in regulation of interferon response and inflammatory mediators during SARS-CoV2 infection and potential therapeutic options.|pdf=|usr=}}
{{tp|p=34144455|t=2021. Identification of oligopeptides from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) non structural protein 8 (NSP8) and their similarities with type 1 angiotensin II receptor key sites.|pdf=|usr=}}
{{tp|p=34103044|t=2021. COVID-19 related multisystem inflammatory syndrome in children (MIS-C): a case series from a tertiary care pediatric hospital in Qatar.|pdf=|usr=}}
{{tp|p=34155633|t=2021. Response to 'COVID-19-associated multisystem inflammatory syndrome in adults with Kawasaki disease-like cutaneous manifestations'.|pdf=|usr=}}
{{tp|p=34160596|t=2021. LSTM-PHV: prediction of human-virus protein-protein interactions by LSTM with word2vec.|pdf=|usr=}}
{{tp|p=34134808|t=2021. Cardiac manifestations and short-term outcomes of multisystem inflammatory syndrome in Middle Eastern children during the COVID-19 pandemic: a case series.|pdf=|usr=}}
{{tp|p=34166652|t=2021. TRP channels in COVID-19 disease: Potential targets for prevention and treatment.|pdf=|usr=}}
{{tp|p=34127868|t=2021. Dynamic properties of SARS-CoV and SARS-CoV-2 RNA-dependent RNA polymerases studied by molecular dynamics simulations.|pdf=|usr=}}
{{tp|p=34163622|t=2021. A microscopic description of SARS-CoV-2 main protease inhibition with Michael acceptors. Strategies for improving inhibitor design.|pdf=|usr=}}
{{tp|p=34168762|t=2021. High-resolution mining of the SARS-CoV-2 main protease conformational space: supercomputer-driven unsupervised adaptive sampling.|pdf=|usr=}}
{{tp|p=34123218|t=2020. Unveiling the molecular mechanism of SARS-CoV-2 main protease inhibition from 137 crystal structures using algebraic topology and deep learning.|pdf=|usr=}}
{{tp|p=34132013|t=2021. alphaV beta6 Integrin: An Intriguing Target for COVID-19 and Related Diseases.|pdf=|usr=}}
{{tp|p=34160124|t=2021. Preliminary Structural Data Revealed That the SARS-CoV-2 B.1.617 Variant's RBD Binds to ACE2 Receptor Stronger Than the Wild Type to Enhance the Infectivity.|pdf=|usr=}}
{{tp|p=34155573|t=2021. Antibody responses after documented COVID-19 disease in patients with autoimmune rheumatic disease.|pdf=|usr=}}
{{tp|p=34127355|t=2021. Type 1 inflammatory endotype relates to low compliance, lung fibrosis, and severe complications in COVID-19.|pdf=|usr=}}
{{tp|p=34183243|t=2021. The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies.|pdf=|usr=}}
{{tp|p=34125495|t=2021. Impact of age and gender on lymphocyte subset counts in patients with COVID-19.|pdf=|usr=}}
{{tp|p=34183244|t=2021. Development of T-cell immunity in a liver and hematopoietic stem cell transplant recipient following coronavirus disease 2019 infection.|pdf=|usr=}}
{{tp|p=34164811|t=2021. IFN-gamma(+) cell response and IFN-gamma release concordance after in vitro SARS-CoV-2 stimulation.|pdf=|usr=}}
{{tp|p=34114541|t=2021. The SARS-CoV-2 B.1.351 lineage (VOC beta) is outgrowing the B.1.1.7 lineage (VOC alpha) in some French regions in April 2021.|pdf=|usr=}}
{{tp|p=34149696|t=2021. SARS-CoV-2 Spike Protein Suppresses ACE2 and Type I Interferon Expression in Primary Cells From Macaque Lung Bronchoalveolar Lavage.|pdf=|usr=}}
{{tp|p=34127926|t=2021. Deconvoluting the T Cell Response to SARS-CoV-2: Specificity Versus Chance and Cognate Cross-Reactivity.|pdf=|usr=}}
{{tp|p=34122423|t=2021. Impaired Cytotoxic Response in PBMCs From Patients With COVID-19 Admitted to the ICU: Biomarkers to Predict Disease Severity.|pdf=|usr=}}
{{tp|p=34122416|t=2021. Potent and Persistent Antibody Response in COVID-19 Recovered Patients.|pdf=|usr=}}
{{tp|p=34122407|t=2021. Macrophages and Dendritic Cells Are Not the Major Source of Pro-Inflammatory Cytokines Upon SARS-CoV-2 Infection.|pdf=|usr=}}
{{tp|p=34113347|t=2021. A Virus-Specific Immune Rheostat in the Immunome of Patients Recovering From Mild COVID-19.|pdf=|usr=}}
{{tp|p=34108966|t=2021. Transcriptional Changes in CD16+ Monocytes May Contribute to the Pathogenesis of COVID-19.|pdf=|usr=}}
{{tp|p=34178896|t=2021. Multisystem Inflammatory Syndrome in Children: Unique Disease or Part of the Kawasaki Disease Spectrum?|pdf=|usr=}}
{{tp|p=34178893|t=2021. Pediatric Multisystem Inflammatory Syndrome in Children as a Challenging Problem for Pediatric Surgeons in the COVID 19 Pandemic-A Case Report.|pdf=|usr=}}
{{tp|p=34178891|t=2021. Efficacy of CytoSorb in a Pediatric Case of Severe Multisystem Infammatory Syndrome (MIS-C): A Clinical Case Report.|pdf=|usr=}}
{{tp|p=34178882|t=2021. Multisystem Inflammatory Syndrome in Children (MIS-C)-A Case Series in December 2020 in Vienna, Austria.|pdf=|usr=}}
{{tp|p=34150685|t=2021. Multisystemic Inflammatory Syndrome and Thrombotic Microangiopathy as Complications of COVID-19 in a Child: A Case Report.|pdf=|usr=}}
{{tp|p=34123977|t=2021. Pediatric Obesity-A Potential Risk Factor for Systemic Inflammatory Syndrome Associated to COVID-19, a Case Report.|pdf=|usr=}}
{{tp|p=34123970|t=2021. Best Practice Recommendations for the Diagnosis and Management of Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS; Multisystem Inflammatory Syndrome in Children, MIS-C) in Switzerland.|pdf=|usr=}}
{{tp|p=34109148|t=2021. Features of Cytokine Storm Identified by Distinguishing Clinical Manifestations in COVID-19.|pdf=|usr=}}
{{tp|p=34183466|t=2021. Clinical Spectrum of Children With Multisystem Inflammatory Syndrome Associated With SARS-CoV-2 Infection.|pdf=|usr=}}
{{tp|p=34116286|t=2021. Variant-genetic and transcript-expression analysis showed a role for the chemokine-receptor CCR5 in COVID-19 severity.|pdf=|usr=}}
{{tp|p=34121407|t=2021. Revealing the Structural Plasticity of SARS-CoV-2 nsp7 and nsp8 Using Structural Proteomics.|pdf=|usr=}}
{{tp|p=34182794|t=2021. Mapping the Nonstructural Transmembrane Proteins of Severe Acute Respiratory Syndrome Coronavirus 2.|pdf=|usr=}}
{{tp|p=34128580|t=2021. Case reports of annular erythema: A diagnostic clue of multisystem inflammatory syndrome in children related to coronavirus disease 2019?|pdf=|usr=}}
{{tp|p=34161567|t=2021. Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.|pdf=|usr=}}
{{tp|p=34186336|t=2021. Innate immunity, inflammation activation and heat-shock protein in COVID-19 pathogenesis.|pdf=|usr=}}
{{tp|p=34118414|t=2021. 7-Ketocholesterol: Effects on viral infections and hypothetical contribution in COVID-19.|pdf=|usr=}}
{{tp|p=34185704|t=2021. IL-13 is a driver of COVID-19 severity.|pdf=|usr=}}
{{tp|p=34166229|t=2021. Autoantibodies stabilize neutrophil extracellular traps in COVID-19.|pdf=|usr=}}
{{tp|p=34143754|t=2021. Duration of post-COVID-19 symptoms is associated with sustained SARS-CoV-2-specific immune responses.|pdf=|usr=}}
{{tp|p=34154708|t=2021. COVID-19 and the multisystem inflammatory syndrome in children: how vulnerable are the kidneys?|pdf=|usr=}}
{{tp|p=34139198|t=2021. SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness.|pdf=|usr=}}
{{tp|p=34171234|t=2021. SARS-CoV-2 variants and considerations of inferring causality on disease severity.|pdf=|usr=}}
{{tp|p=34171232|t=2021. Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.|pdf=|usr=}}
{{tp|p=34171231|t=2021. Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.|pdf=|usr=}}
{{tp|p=34139598|t=2021. Does serotonin deficiency lead to anosmia, ageusia, dysfunctional chemesthesis and increased severity of illness in COVID-19?|pdf=|usr=}}
{{tp|p=34173452|t=2020. Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18.|pdf=|usr=}}
{{tp|p=34121378|t=2021. A case of B.1.1.7 SARS-CoV-2 UK strain with an atypical radiological presentation.|pdf=|usr=}}
{{tp|p=34128696|t=2021. Rapid Increase of SARS-CoV-2 Variant B.1.1.7 Detected in Sewage Samples from England between October 2020 and January 2021.|pdf=|usr=}}
{{tp|p=34119708|t=2021. Is haem the real target of COVID-19?|pdf=|usr=}}
{{tp|p=34177077|t=2021. Synchronized attachment and the Darwinian evolution of coronaviruses CoV-1 and CoV-2.|pdf=|usr=}}
{{tp|p=34143766|t=2021. The landscape of antibody binding in SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=34185681|t=2021. AI-based spectroscopic monitoring of real-time interactions between SARS-CoV-2 and human ACE2.|pdf=|usr=}}
{{tp|p=34140350|t=2021. Characterization of a new SARS-CoV-2 variant that emerged in Brazil.|pdf=|usr=}}
{{tp|p=34121829|t=2021. COVID-19 associated Multisystem Inflammatory Syndrome in Children (MIS-C) guidelines; revisiting the Western New York approach as the pandemic evolves.|pdf=|usr=}}
{{tp|p=34184718|t=2021. Linfohistiocitosis hemofagocitica secundaria y sindrome de liberacion de citoquinas en COVID-19, inverted question markentidades iguales o diferentes?|pdf=|usr=}}
{{tp|p=34127534|t=2021. Genes with 5' terminal oligopyrimidine tracts preferentially escape global suppression of translation by the SARS-CoV-2 Nsp1 protein.|pdf=|usr=}}
{{tp|p=34117209|t=2021. Palmitoylation of SARS-CoV-2 S protein is essential for viral infectivity.|pdf=|usr=}}
{{tp|p=34179694|t=2021. SARS-CoV-2-Induced Multisystem Inflammatory Syndrome in a Young Adult: Case Report.|pdf=|usr=}}
{{tp|p=34124695|t=2021. Protein purification and crystallization of HLA-A 02:01 in complex with SARS-CoV-2 peptides.|pdf=|usr=}}
{{tp|p=34181186|t=2021. Role of Glycoprotein Hemagglutinin-Esterase in COVID-19 Pathophysiology?|pdf=|usr=}}
{{tp|p=34155611|t=2021. Stress Decreases Host Viral Resistance and Increases Covid Susceptibility in Embryonic Stem Cells.|pdf=|usr=}}
{{tp|p=34151035|t=2021. Association between the nasopharyngeal microbiome and metabolome in patients with COVID-19.|pdf=|usr=}}
{{tp|p=34114198|t=2021. Complexities in viral replication strategies as a potential explanation for prevalence of asymptomatic carriers in Covid-19 infections: analytical observation on SARS-Cov2 genome characteristics.|pdf=|usr=}}
{{tp|p=34158856|t=2021. TRPV2-spike protein interaction mediates the entry of SARS-CoV-2 into macrophages in febrile conditions.|pdf=|usr=}}
{{tp|p=34104908|t=2021. Multisystemic inflammatory syndrome in children associated with COVID-19: a single center experience in Turkey.|pdf=|usr=}}
{{tp|p=34160770|t=2021. Clinical characteristics of Kawasaki disease and concurrent pathogens during isolation in COVID-19 pandemic.|pdf=|usr=}}
{{tp|p=34164955|t=2021. Neutralizing Antibody Responses to SARS-CoV-2 in Korean Patients Who Have Recovered from COVID-19.|pdf=|usr=}}
{{tp|p=34115386|t=2021. Kawasaki-like multisystem inflammatory syndrome associated with COVID-19 in an adult: a case report.|pdf=|usr=}}
{{tp|p=34143202|t=2021. Understanding structural malleability of the SARS-CoV-2 proteins and relation to the comorbidities.|pdf=|usr=}}
{{tp|p=34121111|t=2021. Co-mutation modules capture the evolution and transmission patterns of SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34107645|t=2021. Profiling Inflammatory Cytokines in a Cohort Study of Egyptian Patients with COVID-19 Infection.|pdf=|usr=}}
{{tp|p=34116534|t=2021. Letter to the Editor: Immunohistochemical Study of SARS-CoV-2 Viral Entry Factors in the Cornea and Ocular Surface.|pdf=|usr=}}
{{tp|p=34165401|t=2021. Interfering Reactive Cysteine Proteome in Covid-19 Disease.|pdf=|usr=}}
{{tp|p=34161984|t=2021. The Role of Exosomes in the Treatment, Prevention, Diagnosis, and Pathogenesis of COVID-19.|pdf=|usr=}}
{{tp|p=34160586|t=2021. The immunopathobiology of SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=34085882|t=2021. Potential role of free-radical processes in biomolecules damage during COVID-19 and ways of their regulation.|pdf=|usr=}}
{{tp|p=34105843|t=2021. Multisystem inflammatory syndrome in children (MISC): A systematic review.|pdf=|usr=}}
{{tp|p=34100279|t=2021. Be aware of SARS-CoV-2 spike protein: There is more than meets the eye.|pdf=|usr=}}
{{tp|p=34133162|t=2021. Interactive Interface for Graph-Based Analyses of Dynamic H-Bond Networks: Application to Spike Protein S.|pdf=|usr=}}
{{tp|p=34138559|t=2021. Dynamic Profiling of Binding and Allosteric Propensities of the SARS-CoV-2 Spike Protein with Different Classes of Antibodies: Mutational and Perturbation-Based Scanning Reveals the Allosteric Duality of Functionally Adaptable Hotspots.|pdf=|usr=}}
{{tp|p=34145203|t=2021. No Increase in Kawasaki Disease-Like Illnesses During the COVID-19 Pandemic Compared With 4 Previous Years: A Retrospective Analysis.|pdf=|usr=}}
{{tp|p=34176363|t=2021. The Levels of SARS-CoV-2 Specific Antibodies in Human Milk Following Vaccination.|pdf=|usr=}}
{{tp|p=34166506|t=2021. Persistence of Neutralizing Antibody Response up to 1 Year After Asymptomatic or Symptomatic SARS-CoV-2 Infection.|pdf=|usr=}}
{{tp|p=34161170|t=2021. Control of Innate Immune Activation by Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses.|pdf=|usr=}}
{{tp|p=34181987|t=2021. Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing.|pdf=|usr=}}
{{tp|p=34133374|t=2021. Multisystem Inflammatory Syndrome in Children During Induction Chemotherapy in a Newly Diagnosed Pediatric Acute Myeloid Leukemia and Concurrent COVID-19.|pdf=|usr=}}
{{tp|p=34173667|t=2021. Retropharyngeal Edema and Neck Pain in Multisystem Inflammatory Syndrome in Children (MIS-c).|pdf=|usr=}}
{{tp|p=34110264|t=2021. SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.|pdf=|usr=}}
{{tp|p=34105996|t=2021. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.|pdf=|usr=}}
{{tp|p=34132373|t=2021. SARSCoV2 spike proteininduced host inflammatory response signature in human corneal epithelial cells.|pdf=|usr=}}
{{tp|p=34107199|t=2021. Identifying and Tracking SARS-CoV-2 Variants - A Challenge and an Opportunity.|pdf=|usr=}}
{{tp|p=34108657|t=2021. Single-cell epigenomic landscape of peripheral immune cells reveals establishment of trained immunity in individuals convalescing from COVID-19.|pdf=|usr=}}
{{tp|p=34108656|t=2021. Immune memory in individuals with COVID-19.|pdf=|usr=}}
{{tp|p=34183855|t=2021. A STING in the tail for SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34155406|t=2021. SARS-CoV-2-specific hotspots in virus-host interaction networks.|pdf=|usr=}}
{{tp|p=34103714|t=2021. SARS-CoV-2 takes its Toll.|pdf=|usr=}}
{{tp|p=34183391|t=2021. IgA potentiates NETosis in response to viral infection.|pdf=|usr=}}
{{tp|p=34148697|t=2020. Sindrome inflamatorio multisistemico de tipo Kawasaki asociado a COVID-19 en un adulto.|pdf=|usr=}}
{{tp|p=34088785|t=2021. Immune responses to SARS-CoV-2 in the lung.|pdf=|usr=}}

{{tp|p=34179666|t=2021. Landscape-Based Mutational Sensitivity Cartography and Network Community Analysis of the SARS-CoV-2 Spike Protein Structures: Quantifying Functional Effects of the Circulating D614G Variant.|pdf=|usr=}}
{{tp|p=34179644|t=2021. Impact of Expressing Cells on Glycosylation and Glycan of the SARS-CoV-2 Spike Glycoprotein.|pdf=|usr=}}
{{tp|p=34115965|t=2021. Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individuals.|pdf=|usr=}}
{{tp|p=34125890|t=2021. Possible Pleiotropic Effect Of Sry Gene May Increase Male Susceptibility To Covid-19.|pdf=|usr=}}
{{tp|p=34185889|t=2021. An epigenome-wide DNA methylation study of patients with COVID-19.|pdf=|usr=}}
{{tp|p=34101005|t=2021. Antibody response in COVID-19 patients with and without re-positive RT-PCR results during the convalescent phase.|pdf=|usr=}}
{{tp|p=34116667|t=2021. A blood RNA transcriptome signature for COVID-19.|pdf=|usr=}}
{{tp|p=34130987|t=2021. Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis.|pdf=|usr=}}
{{tp|p=34102147|t=2021. New Brazilian variant of the SARS-CoV-2 (P1/Gamma) of COVID-19 in Alagoas state.|pdf=|usr=}}
{{tp|p=34184738|t=2021. DeepIPs: comprehensive assessment and computational identification of phosphorylation sites of SARS-CoV-2 infection using a deep learning-based approach.|pdf=|usr=}}
{{tp|p=34111889|t=2021. Single-cell multi-omics sequencing: application trends, COVID-19, data analysis issues and prospects.|pdf=|usr=}}
{{tp|p=34143953|t=2021. Coupling of N7-methyltransferase and 3'-5' exoribonuclease with SARS-CoV-2 polymerase reveals mechanisms for capping and proofreading.|pdf=|usr=}}
{{tp|p=34139176|t=2021. An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies.|pdf=|usr=}}
{{tp|p=34171305|t=2021. Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.|pdf=|usr=}}
{{tp|p=34162440|t=2021. Deletion of ER-retention motif on SARS-CoV-2 spike protein reduces cell hybrid during cell-cell fusion.|pdf=|usr=}}
{{tp|p=34103487|t=2021. Integrating longitudinal clinical laboratory tests with targeted proteomic and transcriptomic analyses reveal the landscape of host responses in COVID-19.|pdf=|usr=}}
{{tp|p=34127650|t=2021. Potential transmission chains of variant B.1.1.7 and co-mutations of SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34174992|t=2021. Antibody and B cell responses to SARS-CoV-2 infection and vaccination.|pdf=|usr=}}
{{tp|p=34171266|t=2021. SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.|pdf=|usr=}}
{{tp|p=34108680|t=2021. Mucins produced by type II pneumocyte: culprits in SARS-CoV-2 pathogenesis.|pdf=|usr=}}
{{tp|p=34099890|t=2021. Dynamics of the SARS-CoV-2 antibody response up to 10 months after infection.|pdf=|usr=}}
{{tp|p=34117354|t=2021. Structural basis of coronavirus E protein interactions with human PALS1 PDZ domain.|pdf=|usr=}}
{{tp|p=34112887|t=2021. I(nsp1)ecting SARS-CoV-2-ribosome interactions.|pdf=|usr=}}
{{tp|p=34171504|t=2021. A computational analysis of molecular evolution for virulence genes of zoonotic novel coronavirus (COVID-19).|pdf=|usr=}}
{{tp|p=34166886|t=2021. Molecular insight into the genomic variation of SARS-CoV-2 strains from current outbreak.|pdf=|usr=}}
{{tp|p=34157472|t=2021. Multilevel systems biology analysis of lung transcriptomics data identifies key miRNAs and potential miRNA target genes for SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=34184973|t=2021. Emergence of the novel SARS-CoV-2 lineage VUI-NP13L and massive spread of P.2 in South Brazil.|pdf=|usr=}}
{{tp|p=34125658|t=2021. Rapidly emerging SARS-CoV-2 B.1.1.7 sub-lineage in the United States of America with spike protein D178H and membrane protein V70L mutations.|pdf=|usr=}}
{{tp|p=34150352|t=2021. Identification of Monocytes Associated with Severe COVID-19 in the PBMCs of Severely Infected patients Through Single-Cell Transcriptome Sequencing.|pdf=|usr=}}
{{tp|p=34179146|t=2021. SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier Integrity.|pdf=|usr=}}
{{tp|p=34124207|t=2021. The Notch Pathway: A Link Between COVID-19 Pathophysiology and Its Cardiovascular Complications.|pdf=|usr=}}
{{tp|p=34163530|t=2021. Human MicroRNAs Interacting With SARS-CoV-2 RNA Sequences: Computational Analysis and Experimental Target Validation.|pdf=|usr=}}
{{tp|p=34122515|t=2021. Transcriptional Start Site Coverage Analysis in Plasma Cell-Free DNA Reveals Disease Severity and Tissue Specificity of COVID-19 Patients.|pdf=|usr=}}
{{tp|p=34122498|t=2021. A Computational Framework for Pattern Detection on Unaligned Sequences: An Application on SARS-CoV-2 Data.|pdf=|usr=}}
{{tp|p=34177962|t=2021. Detailed Multiplex Analysis of SARS-CoV-2 Specific Antibodies in COVID-19 Disease.|pdf=|usr=}}
{{tp|p=34177923|t=2021. SARS-CoV-2 ORF8 Forms Intracellular Aggregates and Inhibits IFNgamma-Induced Antiviral Gene Expression in Human Lung Epithelial Cells.|pdf=|usr=}}
{{tp|p=34177897|t=2021. Unbiased Analysis of Temporal Changes in Immune Serum Markers in Acute COVID-19 Infection With Emphasis on Organ Failure, Anti-Viral Treatment, and Demographic Characteristics.|pdf=|usr=}}
{{tp|p=34163491|t=2021. Serum Complement C3 and C4 and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression.|pdf=|usr=}}
{{tp|p=34163490|t=2021. PD-L1 Dysregulation in COVID-19 Patients.|pdf=|usr=}}
{{tp|p=34149717|t=2021. Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets.|pdf=|usr=}}
{{tp|p=34146758|t=2021. Analysis of endogenous oxidative damage markers and association with pulmonary involvement severity in patients with SARS-CoV-2 pneumonia.|pdf=|usr=}}
{{tp|p=34110618|t=2021. Dynamic Changes in the Immune Response Correlate with Disease Severity and Outcomes During Infection with SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34163183|t=2021. Effect of Genomic and Amino Acid Sequence Mutation on Virulence and Therapeutic Target of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS COV-2).|pdf=|usr=}}
{{tp|p=34147651|t=2021. Global variation in SARS-CoV-2 proteome and its implication in pre-lockdown emergence and dissemination of 5 dominant SARS-CoV-2 clades.|pdf=|usr=}}
{{tp|p=34146731|t=2021. Recent progress on the mutations of SARS-CoV-2 spike protein and suggestions for prevention and controlling of the pandemic.|pdf=|usr=}}
{{tp|p=34147667|t=2021. Detection of SARS-CoV-2 variants requires urgent global coordination.|pdf=|usr=}}
{{tp|p=34067854|t=2021. Viral Interactions with Adaptor-Protein Complexes: A Ubiquitous Trait among Viral Species.|pdf=|usr=}}
{{tp|p=34179732|t=2021. Dissecting the common and compartment-specific features of COVID-19 severity in the lung and periphery with single-cell resolution.|pdf=|usr=}}
{{tp|p=34111453|t=2021. Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19.|pdf=|usr=}}
{{tp|p=34112485|t=2021. Reply to "Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium".|pdf=|usr=}}
{{tp|p=34112484|t=2021. Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium.|pdf=|usr=}}
{{tp|p=34112483|t=2021. Reply to "Protective effects of eosinophils against COVID-19: More than an ACE(2) in the hole?"|pdf=|usr=}}
{{tp|p=34112482|t=2021. Protective effects of eosinophils against COVID-19: More than an ACE(2) in the hole?|pdf=|usr=}}
{{tp|p=34181169|t=2021. SARS-CoV-2 signaling pathway map: A functional landscape of molecular mechanisms in COVID-19.|pdf=|usr=}}
{{tp|p=34137173|t=2021. Single-cell RNA sequencing identify SDCBP in ACE2-positive bronchial epithelial cells negatively correlates with COVID-19 severity.|pdf=|usr=}}
{{tp|p=34156227|t=2021. Anchor-Locker Binding Mechanism of the Coronavirus Spike Protein to Human ACE2: Insights from Computational Analysis.|pdf=|usr=}}
{{tp|p=34160366|t=2021. Zonulin as a biomarker and potential therapeutic target in multisystem inflammatory syndrome in children.|pdf=|usr=}}
{{tp|p=34153860|t=2021. Lack of active SARS-CoV-2 virus in a subset of PCR-positive COVID-19 congregate care patients.|pdf=|usr=}}
{{tp|p=34157514|t=2021. SARS-CoV-2 spike protein removes lipids from model membranes and interferes with the capacity of high density lipoprotein to exchange lipids.|pdf=|usr=}}
{{tp|p=34107824|t=2021. Of mitochondrion and COVID-19.|pdf=|usr=}}
{{tp|p=34146596|t=2021. The incubation period of the SARS-CoV-2 B1.1.7 variant is shorter than that of other strains.|pdf=|usr=}}
{{tp|p=34176716|t=2021. Virological and genomic analysis of SARS-CoV-2 from a favipiravir clinical trial cohort.|pdf=|usr=}}
{{tp|p=34175236|t=2021. New COVID-19 variant (B.1.1.7): Forecasting the occasion of virus and the related meteorological factors.|pdf=|usr=}}
{{tp|p=34168484|t=2021. Gut Microbiota Dysbiosis Correlates with Abnormal Immune Response in Moderate COVID-19 Patients with Fever.|pdf=|usr=}}
{{tp|p=34163208|t=2021. Longitudinal Antibody Dynamics Against Structural Proteins of SARS-CoV-2 in Three COVID-19 Patients Shows Concurrent Development of IgA, IgM, and IgG.|pdf=|usr=}}
{{tp|p=34184438|t=2021. The First Case of Multisystem Inflammatory Syndrome in Adult after COVID-19 in Korea.|pdf=|usr=}}
{{tp|p=34138483|t=2021. Soluble angiotensin-converting enzyme 2 is transiently elevated in COVID-19 and correlates with specific inflammatory and endothelial markers.|pdf=|usr=}}
{{tp|p=34138461|t=2021. Medium-term serostatus in Spanish case series recovered from SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=34125455|t=2021. Molecular biology of the SARs-CoV-2 spike protein: A review of current knowledge.|pdf=|usr=}}
{{tp|p=34101203|t=2021. Prevalence of IgG antibodies induced by the SARS-COV-2 virus in asymptomatic adults in Nuevo Leon, Mexico.|pdf=|usr=}}
{{tp|p=34170519|t=2021. Over 1-year duration and age difference of SARS-CoV-2 antibodies in convalescent COVID-19 patients.|pdf=|usr=}}
{{tp|p=34174328|t=2021. A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process.|pdf=|usr=}}
{{tp|p=34116123|t=2021. Can We AlphaFold Our Way Out of the Next Pandemic?|pdf=|usr=}}
{{tp|p=34161778|t=2021. The Inherent Dynamics and Interaction Sites of the SARS-CoV-2 Nucleocapsid N-Terminal Region.|pdf=|usr=}}
{{tp|p=34153515|t=2021. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Genome Sequencing from Post-Mortem Formalin-Fixed, Paraffin-Embedded Lung Tissues.|pdf=|usr=}}
{{tp|p=34121768|t=2021. Comparative analysis of non structural protein 1 of SARS-CoV2 with SARS-CoV1 and MERS-CoV: An in silico study.|pdf=|usr=}}
{{tp|p=34163172|t=2021. Structural Zero Data of COVID-19 Discovers Exodus Probabilities.|pdf=|usr=}}
{{tp|p=34180678|t=2021. Genetic Variability of the SARS-CoV-2 Pocketome.|pdf=|usr=}}
{{tp|p=34124702|t=2021. SARS-CoV-2 emerging variants in Africa: view from Gabon.|pdf=|usr=}}
{{tp|p=34118186|t=2021. Persistence of SARS-CoV-2 RNA in lung tissue after mild COVID-19.|pdf=|usr=}}
{{tp|p=34124694|t=2021. Inflammatory biomarkers in COVID-19-associated multisystem inflammatory syndrome in children, Kawasaki disease, and macrophage activation syndrome: a cohort study.|pdf=|usr=}}
{{tp|p=34163002|t=2021. An evidence that SARS-Cov-2/COVID-19 spike protein (SP) damages hematopoietic stem/progenitor cells in the mechanism of pyroptosis in Nlrp3 inflammasome-dependent manner.|pdf=|usr=}}
{{tp|p=34168074|t=2021. Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19.|pdf=|usr=}}
{{tp|p=34182784|t=2021. Identification of a High-Frequency Intrahost SARS-CoV-2 Spike Variant with Enhanced Cytopathic and Fusogenic Effects.|pdf=|usr=}}
{{tp|p=34182775|t=2021. Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.|pdf=|usr=}}
{{tp|p=34111060|t=2021. Genomic Surveillance for SARS-CoV-2 Variants Circulating in the United States, December 2020-May 2021.|pdf=|usr=}}
{{tp|p=34118193|t=2021. Global analysis of protein-RNA interactions in SARS-CoV-2-infected cells reveals key regulators of infection.|pdf=|usr=}}
{{tp|p=34146663|t=2021. In-silico analysis of Covid-19 genome sequences of Indian origin: Impact of mutations in identification of SARS-Co-V2.|pdf=|usr=}}
{{tp|p=34133855|t=2021. Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes.|pdf=|usr=}}
{{tp|p=34133854|t=2021. Treatment of Multisystem Inflammatory Syndrome in Children.|pdf=|usr=}}
{{tp|p=34168138|t=2021. The architecture of the SARS-CoV-2 RNA genome inside virion.|pdf=|usr=}}
{{tp|p=34155209|t=2021. Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain.|pdf=|usr=}}
{{tp|p=34145263|t=2021. Immunological imprinting of the antibody response in COVID-19 patients.|pdf=|usr=}}
{{tp|p=34140485|t=2021. Multianalyte serology in home-sampled blood enables an unbiased assessment of the immune response against SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34162970|t=2021. Natural variants in SARS-CoV-2 Spike protein pinpoint structural and functional hotspots with implications for prophylaxis and therapeutic strategies.|pdf=|usr=}}
{{tp|p=34162945|t=2021. Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals.|pdf=|usr=}}
{{tp|p=34131210|t=2021. Attractive and repulsive residue fragments at the interface of SARS-CoV-2 and hACE2.|pdf=|usr=}}
{{tp|p=34117310|t=2021. The major genetic risk factor for severe COVID-19 does not show any association among South Asian populations.|pdf=|usr=}}
{{tp|p=34131072|t=2021. Mn(2+) coordinates Cap-0-RNA to align substrates for efficient 2'-O-methyl transfer by SARS-CoV-2 nsp16.|pdf=|usr=}}
{{tp|p=34106169|t=2021. inverted question markQue sabemos de la enfermedad de Kawasaki y COVID 19?|pdf=|usr=}}
{{tp|p=34181887|t=2021. Nuclear factor-kappa B and its role in inflammatory lung disease.|pdf=|usr=}}
{{tp|p=34144638|t=2021. Does COVID-19 alter the oxyhemoglobin dissociation curve? - An observational cohort study using a mixed-effect modelling.|pdf=|usr=}}
{{tp|p=34116589|t=2021. Elevated soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients.|pdf=|usr=}}
{{tp|p=34145459|t=2021. Large-Scale Identification of T-Cell Epitopes Derived From Severe Acute Respiratory Syndrome Coronavirus 2 for the Development of Peptide Vaccines Against Coronavirus Disease 2019.|pdf=|usr=}}
{{tp|p=34158670|t=2021. A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19.|pdf=|usr=}}
{{tp|p=34108654|t=2021. SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse.|pdf=|usr=}}
{{tp|p=34158638|t=2021. Cryo-EM structure of SARS-CoV-2 ORF3a in lipid nanodiscs.|pdf=|usr=}}
{{tp|p=34108727|t=2021. How a rampant coronavirus variant blunts our immune defences.|pdf=|usr=}}
{{tp|p=34108702|t=2021. Embrace the WHO's new naming system for coronavirus variants.|pdf=|usr=}}
{{tp|p=34158664|t=2021. Delta coronavirus variant: scientists brace for impact.|pdf=|usr=}}
{{tp|p=34127832|t=2021. A long-term perspective on immunity to COVID.|pdf=|usr=}}
{{tp|p=34060442|t=2021. [Prediction of the epitopes of SARS-CoV-2 by immunoinformatics].|pdf=|usr=}}

{{tp|p=34146538|t=2021. Peptides of H. sapiens and P. falciparum that are predicted to bind strongly to HLA-A24:02 and homologous to a SARS-CoV-2 peptide.|pdf=|usr=}}
{{tp|p=34143752|t=2021. SARS-CoV-2-Specific Antibody and T Cell Response Kinetics According to Symptom Severity.|pdf=|usr=}}
{{tp|p=34138748|t=2021. Early and High SARS-CoV-2 Neutralizing Antibodies Are Associated with Severity in COVID-19 Patients from India.|pdf=|usr=}}
{{tp|p=34161644|t=2021. Exploring the Druggability of Conserved RNA Regulatory Elements in the SARS-CoV-2 Genome.|pdf=|usr=}}
{{tp|p=34149107|t=2021. Innentitelbild: Synthetic Homogeneous Glycoforms of the SARS-CoV-2 Spike Receptor-Binding Domain Reveals Different Binding Profiles of Monoclonal Antibodies (Angew. Chem. 23/2021).|pdf=|usr=}}
{{tp|p=34154787|t=2021. Eosinophils in antiviral immunity and (perhaps) a benefit of having asthma during the SARS-CoV2 pandemic.|pdf=|usr=}}
{{tp|p=34113953|t=2022. Antibody persistency and trend post-SARS-CoV-2 infection at eight months.|pdf=|usr=}}
{{tp|p=34174806|t=2021. Innate immunity in COVID-19: Drivers of pathogenesis and potential therapeutic targets.|pdf=|usr=}}
{{tp|p=34181320|t=2021. Evaluation of Serologic Changes of IgG and IgM Antibodies Associated with SARS-COV-2 in Cancer Patients: A Cohort Seroprevalence Study.|pdf=|usr=}}
{{tp|p=34127503|t=2021. Can PIMS-TS lead to a facial nerve palsy?|pdf=|usr=}}
{{tp|p=34173107|t=2021. Dynamics of Antibodies to Various Antigens of the SARS-CoV-2 Coronavirus in Patients with Confirmed COVID-19 Infection.|pdf=|usr=}}
{{tp|p=34117968|t=2021. Mitochondrial DNA Heteroplasmy as an Informational Reservoir Dynamically Linked to Metabolic and Immunological Processes Associated with COVID-19 Neurological Disorders.|pdf=|usr=}}
{{tp|p=34166618|t=2021. Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics.|pdf=|usr=}}
{{tp|p=34166617|t=2021. Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.|pdf=|usr=}}
{{tp|p=34146478|t=2021. Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4(+) T cell help.|pdf=|usr=}}
{{tp|p=34151306|t=2021. Serological analysis reveals an imbalanced IgG subclass composition associated with COVID-19 disease severity.|pdf=|usr=}}
{{tp|p=34124701|t=2021. Young infants exhibit robust functional antibody responses and restrained IFN-gamma production to SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34112954|t=2021. SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target.|pdf=|usr=}}
{{tp|p=34146659|t=2021. TRIM28 regulates SARS-CoV-2 cell entry by targeting ACE2.|pdf=|usr=}}
{{tp|p=34139154|t=2021. A time-resolved proteomic and prognostic map of COVID-19.|pdf=|usr=}}
{{tp|p=34166080|t=2021. Macrophages: Potential Therapeutic Target of Myocardial Injury in COVID-19.|pdf=|usr=}}
{{tp|p=34105720|t=2021. Increased household secondary attacks rates with Variant of Concern SARS-CoV-2 index cases.|pdf=|usr=}}
{{tp|p=34155047|t=2021. Multisystem inflammatory syndrome in an adult after SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=34122620|t=2021. Correlation Analysis between the Viral Load and the Progression of COVID-19.|pdf=|usr=}}
{{tp|p=34109017|t=2021. The evolving proteome of SARS-CoV-2 predominantly uses mutation combination strategy for survival.|pdf=|usr=}}
{{tp|p=34104356|t=2021. Dissecting nucleotide selectivity in viral RNA polymerases.|pdf=|usr=}}
{{tp|p=34120861|t=2021. SARS-CoV-2 and Multisystem Inflammatory Syndrome In Children (MIS-C).|pdf=|usr=}}
{{tp|p=34186492|t=2021. NK cells on the ViP stage of COVID-19.|pdf=|usr=}}
{{tp|p=34158771|t=2021. Functional and Structural Characterization of SARS-Cov-2 Spike Protein: An In Silico Study.|pdf=|usr=}}
{{tp|p=34185144|t=2021. Epidemiological analysis in support of hypothesis that D614G virus mutation is a major contributing factor to chemosensory dysfunction in COVID-19 patients.|pdf=|usr=}}
{{tp|p=34149667|t=2021. SARS-CoV-2-Host Chimeric RNA-Sequencing Reads Do Not Necessarily Arise From Virus Integration Into the Host DNA.|pdf=|usr=}}
{{tp|p=34179075|t=2021. Heparan Sulfate Facilitates Spike Protein-Mediated SARS-CoV-2 Host Cell Invasion and Contributes to Increased Infection of SARS-CoV-2 G614 Mutant and in Lung Cancer.|pdf=|usr=}}
{{tp|p=34150848|t=2021. Sex-Related Overactivation of NLRP3 Inflammasome Increases Lethality of the Male COVID-19 Patients.|pdf=|usr=}}
{{tp|p=34109214|t=2021. Scrutinizing Coronaviruses Using Publicly Available Bioinformatic Tools: The Viral Structural Proteins as a Case Study.|pdf=|usr=}}
{{tp|p=34136461|t=2021. Proliferation of SARS-CoV-2 B.1.1.7 Variant in Pakistan-A Short Surveillance Account.|pdf=|usr=}}
{{tp|p=34123997|t=2021. SARS-CoV-2 B.1.1.7 UK Variant of Concern Lineage-Related Perceptions, COVID-19 Vaccine Acceptance and Travel Worry Among Healthcare Workers.|pdf=|usr=}}
{{tp|p=34175388|t=2021. Variants in AGTR2 gene in Maya people with COVID-19.|pdf=|usr=}}
{{tp|p=34131597|t=2021. A bioinformatics approach for identifying potential molecular mechanisms and key genes involved in COVID-19 associated cardiac remodeling.|pdf=|usr=}}
{{tp|p=34131596|t=2021. SARS-CoV-2 mutations altering regulatory properties: Deciphering host's and virus's perspectives.|pdf=|usr=}}
{{tp|p=34152577|t=2021. Comparative study of predicted miRNA between Indonesia and China (Wuhan) SARS-CoV-2: a bioinformatics analysis.|pdf=|usr=}}
{{tp|p=34140652|t=2021. Role of DAMPs in respiratory virus-induced acute respiratory distress syndrome-with a preliminary reference to SARS-CoV-2 pneumonia.|pdf=|usr=}}
{{tp|p=34159627|t=2021. Genome-wide association analysis of COVID-19 mortality risk in SARS-CoV-2 genomes identifies mutation in the SARS-CoV-2 spike protein that colocalizes with P.1 of the Brazilian strain.|pdf=|usr=}}
{{tp|p=34183789|t=2021. An integrative multiomics analysis identifies putative causal genes for COVID-19 severity.|pdf=|usr=}}
{{tp|p=34179538|t=2021. Computational search of hybrid human/SARS-CoV-2 dsRNA reveals unique viral sequences that diverge from those of other coronavirus strains.|pdf=|usr=}}
{{tp|p=34142358|t=2021. The role of estradiol in the immune response against COVID-19.|pdf=|usr=}}
{{tp|p=34116863|t=2021. Antigen presentation in SARS-CoV-2 infection: the role of class I HLA and ERAP polymorphisms.|pdf=|usr=}}
{{tp|p=34166623|t=2021. Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.|pdf=|usr=}}
{{tp|p=34145089|t=2021. Electron microscopy imaging of SARS-CoV-2 at different temperatures.|pdf=|usr=}}
{{tp|p=34137349|t=2021. SARS-CoV-2 late shedding may be infectious between immunocompromised hosts.|pdf=|usr=}}
{{tp|p=34163216|t=2021. KDELC1 and TRMT1 Serve as Prognosis-Related SARS-CoV-2 Proteins Binding Human mRNAs and Promising Biomarkers in Clear Cell Renal Cell Carcinoma.|pdf=|usr=}}
{{tp|p=34128960|t=2021. Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics.|pdf=|usr=}}
{{tp|p=34128959|t=2021. Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19.|pdf=|usr=}}
{{tp|p=34140221|t=2021. Immune response to COVID-19 in older adults.|pdf=|usr=}}
{{tp|p=34150910|t=2021. Analysis of Lymphocyte Subpopulations and Cytokines in COVID-19-Associated Pneumonia and Community-Acquired Pneumonia.|pdf=|usr=}}
{{tp|p=34130119|t=2021. The immunological response among COVID-19 patients with acute respiratory distress syndrome.|pdf=|usr=}}
{{tp|p=34118739|t=2021. SARS-CoV-2 and Plasmodium falciparum are probably adopting Analogous strategy to invade erythrocytes.|pdf=|usr=}}
{{tp|p=34159904|t=2021. B cells and COVID-19: Lessons from agammaglobulinemia patients and the study of functional B cell polymorphisms.|pdf=|usr=}}
{{tp|p=34185327|t=2021. Unrecognized introduction of SARS-CoV-2 variants of concern to Central Africa: Import and local transmission of B.1.1.7 in Gabon in the very early stage of the variant spread to the African continent.|pdf=|usr=}}
{{tp|p=34110159|t=2021. Structural and Dynamical Differences in the Spike Protein RBD in the SARS-CoV-2 Variants B.1.1.7 and B.1.351.|pdf=|usr=}}
{{tp|p=34110168|t=2021. Conformational Dynamics in the Interaction of SARS-CoV-2 Papain-like Protease with Human Interferon-Stimulated Gene 15 Protein.|pdf=|usr=}}
{{tp|p=34161095|t=2021. Allosteric Cross-Talk among Spike's Receptor-Binding Domain Mutations of the SARS-CoV-2 South African Variant Triggers an Effective Hijacking of Human Cell Receptor.|pdf=|usr=}}
{{tp|p=34155521|t=2021. An early assessment of a case fatality risk associated with P.1 SARS-CoV-2 lineage in Brazil: an ecological study.|pdf=|usr=}}
{{tp|p=34170328|t=2021. Intensive Care Needs and Short-Term Outcome of Multisystem Inflammatory Syndrome in Children (MIS-C): Experience from North India.|pdf=|usr=}}
{{tp|p=34106002|t=2021. Viral and Host Transcriptomes in SARS-CoV-2-Infected Human Lung Cells.|pdf=|usr=}}
{{tp|p=34160250|t=2021. SARS-CoV-2 Spike Protein Induces Paracrine Senescence and Leukocyte Adhesion in Endothelial Cells.|pdf=|usr=}}
{{tp|p=34133899|t=2021. Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice.|pdf=|usr=}}
{{tp|p=34133897|t=2021. SARS-CoV-2 NSP12 Protein Is Not an Interferon-beta Antagonist.|pdf=|usr=}}
{{tp|p=34166701|t=2021. Comparison of SARS-CoV-2 N gene real-time RT-PCR targets and commercially available mastermixes.|pdf=|usr=}}
{{tp|p=34110391|t=2021. Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34143756|t=2021. COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes.|pdf=|usr=}}
{{tp|p=34149046|t=2021. Editorial: Revised World Health Organization (WHO) Terminology for Variants of Concern and Variants of Interest of SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34149939|t=2021. Hemophagocytic lymphohistocytosis in a COVID-19 patient in the acute phase: case report.|pdf=|usr=}}
{{tp|p=34153417|t=2021. Construction of an autophagy interaction network based on competitive endogenous RNA reveals the key pathways and central genes of SARS-CoV-2 infection in vivo.|pdf=|usr=}}
{{tp|p=34119626|t=2021. Conformational dynamics of 13 amino acids long NSP11 of SARS-CoV-2 under membrane mimetics and different solvent conditions.|pdf=|usr=}}
{{tp|p=34132615|t=2021. Spike Protein Antibodies Mediate the Apparent Correlation between SARS-CoV-2 Nucleocapsid Antibodies and Neutralization Test Results.|pdf=|usr=}}
{{tp|p=34132580|t=2021. Structural Basis and Function of the N Terminus of SARS-CoV-2 Nonstructural Protein 1.|pdf=|usr=}}
{{tp|p=34069681|t=2021. Global Genomic Analysis of SARS-CoV-2 RNA Dependent RNA Polymerase Evolution and Antiviral Drug Resistance.|pdf=|usr=}}
{{tp|p=34163035|t=2021. Emergence and spread of a SARS-CoV-2 lineage A variant (A.23.1) with altered spike protein in Uganda.|pdf=|usr=}}
{{tp|p=34126625|t=2021. Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection.|pdf=|usr=}}
{{tp|p=34151992|t=2021. Kinetics of Anti-SARS-CoV-2 IgG among healthcare workers in a General Hospital.|pdf=|usr=}}
{{tp|p=34185793|t=2021. Alteration of L-Dopa decarboxylase expression in SARS-CoV-2 infection and its association with the interferon-inducible ACE2 isoform.|pdf=|usr=}}
{{tp|p=34166398|t=2021. SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms.|pdf=|usr=}}
{{tp|p=34161373|t=2021. The human microbiome and COVID-19: A systematic review.|pdf=|usr=}}
{{tp|p=34161337|t=2021. SARS-CoV-2 uses major endothelial integrin alphavbeta3 to cause vascular dysregulation in-vitro during COVID-19.|pdf=|usr=}}
{{tp|p=34115768|t=2021. Longitudinal changes in IgG levels among COVID-19 recovered patients: A prospective cohort study.|pdf=|usr=}}
{{tp|p=34106957|t=2021. SARS-CoV-2 Envelope (E) protein interacts with PDZ-domain-2 of host tight junction protein ZO1.|pdf=|usr=}}
{{tp|p=34101725|t=2021. Potential G-quadruplexes and i-Motifs in the SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34181691|t=2021. The endogenous cellular protease inhibitor SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity.|pdf=|usr=}}
{{tp|p=34146958|t=2021. SARS-CoV2 infection impairs the metabolism and redox function of cellular glutathione.|pdf=|usr=}}
{{tp|p=34186259|t=2021. Cellular senescence is a potential severity factor for COVID-19: Suitable targets required to eliminate cellular senescence.|pdf=|usr=}}
{{tp|p=34159291|t=2021. A Kawasaki-like illness in an adult with recent SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=34134991|t=2021. Targeting highly pathogenic coronavirus-induced apoptosis reduces viral pathogenesis and disease severity.|pdf=|usr=}}
{{tp|p=34170629|t=2021. The emergence of SARS-CoV-2 variants in Dhaka city, Bangladesh.|pdf=|usr=}}
{{tp|p=34157565|t=2021. Age- and airway disease related gene expression patterns of key SARS-CoV-2 entry factors in human nasal epithelia.|pdf=|usr=}}
{{tp|p=34141447|t=2021. Structural phylogenetic analysis reveals lineage-specific RNA repetitive structural motifs in all coronaviruses and associated variations in SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34118359|t=2021. Positive selection as a key player for SARS-CoV-2 pathogenicity: Insights into ORF1ab, S and E genes.|pdf=|usr=}}
{{tp|p=34073934|t=2021. Identification of Novel Candidate CD8(+) T Cell Epitopes of the SARS-CoV2 with Homology to Other Seasonal Coronaviruses.|pdf=|usr=}}
{{tp|p=34130462|t=2021. Relational interaction between T-lymphocytes and SARS-CoV-2: A review.|pdf=|usr=}}
{{tp|p=34076457|t=2021. Radiologic Manifestations of Multisystem Inflammatory Syndrome in Children.|pdf=|usr=}}
{{tp|p=34076453|t=2021. Reply to "Radiologic Manifestations of Multisystem Inflammatory Syndrome in Children".|pdf=|usr=}}
{{tp|p=34159794|t=2021. Endothelial metabolism in pulmonary vascular homeostasis and acute respiratory distress syndrome.|pdf=|usr=}}
{{tp|p=34183280|t=2021. Apendicitis aguda en ninos con sindrome inflamatorio multisistemico pediatrico asociado a SARS-CoV-2 (SIM-PedS). Una complicacion a considerar.|pdf=|usr=}}
{{tp|p=34132382|t=2021. The kidnapping of mitochondrial function associated with the SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=34160551|t=2021. Local memory CD4 T cell niches in respiratory viral infection.|pdf=|usr=}}
{{tp|p=34117201|t=2021. Ocular Manifestations of Multisystem Inflammatory Syndrome in Children with COVID-19.|pdf=|usr=}}
{{tp|p=34117202|t=2021. Intrafamilial Spread and Altered Symptomatology of SARS-CoV-2, During Predominant Circulation of Lineage B.1.1.7 Variant in Israel.|pdf=|usr=}}
{{tp|p=34158313|t=2021. Duration of Effective Antibody Levels After COVID-19.|pdf=|usr=}}
{{tp|p=34158312|t=2021. Mild SARS-CoV-2 Infections and Neutralizing Antibody Titers.|pdf=|usr=}}
{{tp|p=34078749|t=2021. iciHHV-6 in a Patient With Multisystem Inflammatory Syndrome in Children.|pdf=|usr=}}
{{tp|p=34137759|t=2021. Quantitative analysis of ACE2 binding to coronavirus spike proteins: SARS-CoV-2 vs. SARS-CoV and RaTG13.|pdf=|usr=}}
{{tp|p=34132301|t=2021. Molecular insights into the binding variance of the SARS-CoV-2 spike with human, cat and dog ACE2 proteins.|pdf=|usr=}}
{{tp|p=34077977|t=2021. Extracellular Vesicles and Citrullinated Histone H3 in Coronavirus Disease 2019 Patients.|pdf=|usr=}}

{{tp|p=34129731|t=2021. Multisystem inflammatory syndrome in children occurred in one of four thousand children with severe acute respiratory syndrome coronavirus 2.|pdf=|usr=}}
{{tp|p=34094637|t=2021. Cellular Tropism of SARS-CoV-2 across Human Tissues and Age-related Expression of ACE2 and TMPRSS2 in Immune-inflammatory Stromal Cells.|pdf=|usr=}}
{{tp|p=34303698|t=2021. Trajectory of Growth of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in Houston, Texas, January through May 2021, Based on 12,476 Genome Sequences.|pdf=|usr=}}
{{tp|p=34231390|t=2021. Erythrocytes identify complement activation in patients with COVID-19.|pdf=|usr=}}
{{tp|p=34235568|t=2021. Glycosylation of SARS-CoV-2: structural and functional insights.|pdf=|usr=}}
{{tp|p=34389878|t=2021. The challenge of structural heterogeneity in the native mass spectrometry studies of the SARS-CoV-2 spike protein interactions with its host cell-surface receptor.|pdf=|usr=}}
{{tp|p=34356359|t=2021. Time Course of Redox Biomarkers in COVID-19 Pneumonia: Relation with Inflammatory, Multiorgan Impairment Biomarkers and CT Findings.|pdf=|usr=}}
{{tp|p=34450201|t=2021. Identification of Niemann-Pick C1 protein as a potential novel SARS-CoV-2 intracellular target.|pdf=|usr=}}
{{tp|p=34261445|t=2021. Whole genome sequencing and phylogenetic analysis of six SARS-CoV-2 strains isolated during COVID-19 pandemic in Tunisia, North Africa.|pdf=|usr=}}
{{tp|p=34210694|t=2021. Giant coronary artery aneurysm as a feature of coronavirus-related inflammatory syndrome.|pdf=|usr=}}
{{tp|p=34192188|t=2021. Paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): a narrative review and the viewpoint of the Latin American Society of Pediatric Intensive Care (SLACIP) Sepsis Committee.|pdf=|usr=}}
{{tp|p=34188776|t=2021. Evolution, correlation, structural impact and dynamics of emerging SARS-CoV-2 variants.|pdf=|usr=}}
{{tp|p=34310359|t=2021. Learning about Kawasaki disease from COVID-19 and the Multisystem Inflammatory Syndrome in Children.|pdf=|usr=}}
{{tp|p=34320263|t=2021. Facing the wrath of enigmatic mutations: a review on the emergence of severe acute respiratory syndrome coronavirus 2 variants amid coronavirus disease-19 pandemic.|pdf=|usr=}}
{{tp|p=34212320|t=2021. Increased Levels of serum Pentraxin 3 in Critical Coronavirus Disease-2019 Patients.|pdf=|usr=}}
{{tp|p=34289974|t=2021. Metabolomic analyses reveals new stage-specific features of the COVID-19.|pdf=|usr=}}
{{tp|p=34142653|t=2021. Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021.|pdf=|usr=}}
{{tp|p=34136131|t=2021. Interactive SARS-CoV-2 mutation timemaps.|pdf=|usr=}}
{{tp|p=34186206|t=2021. Upregulation of oxidative stress gene markers during SARS-COV-2 viral infection.|pdf=|usr=}}
{{tp|p=34307358|t=2021. Potential Impact of Diabetes and Obesity on Alveolar Type 2 (AT2)-Lipofibroblast (LIF) Interactions After COVID-19 Infection.|pdf=|usr=}}
{{tp|p=34268136|t=2021. The Gut Microbiota of Critically Ill Patients With COVID-19.|pdf=|usr=}}
{{tp|p=34249864|t=2021. Catalytic Dyad Residues His41 and Cys145 Impact the Catalytic Activity and Overall Conformational Fold of the Main SARS-CoV-2 Protease 3-Chymotrypsin-Like Protease.|pdf=|usr=}}
{{tp|p=34220703|t=2021. Covid-19 and Growth Hormone/Insulin-Like Growth Factor 1: Study in Critically and Non-Critically Ill Patients.|pdf=|usr=}}
{{tp|p=34194420|t=2021. sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection.|pdf=|usr=}}
{{tp|p=34307408|t=2021. Retinal Microcirculation as a Correlate of a Systemic Capillary Impairment After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.|pdf=|usr=}}
{{tp|p=34307393|t=2021. Elevation of Serum Cytokine Profiles and Liver Metabolomic Normalization in Early Convalescence of COVID-19 Patients.|pdf=|usr=}}
{{tp|p=34262921|t=2021. Novel Highly Divergent SARS-CoV-2 Lineage With the Spike Substitutions L249S and E484K.|pdf=|usr=}}
{{tp|p=34277453|t=2021. Comparison of COVID-19 and Lung Cancer via Reactive Oxygen Species Signaling.|pdf=|usr=}}
{{tp|p=34261300|t=2021. Comparative study: nonsynonymous and synonymous substitution of SARS-CoV-2, SARS-CoV, and MERS-CoV genome.|pdf=|usr=}}
{{tp|p=34261299|t=2021. A protein interactions map of multiple organ systems associated with COVID-19 disease.|pdf=|usr=}}
{{tp|p=34132630|t=2021. Effect of COVID-19 precautions on the gut microbiota and nosocomial infections.|pdf=|usr=}}
{{tp|p=34100340|t=2021. The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort.|pdf=|usr=}}
{{tp|p=34217989|t=2021. COVID-19 variants in India: Potential role in second wave and impact on vaccination.|pdf=|usr=}}
{{tp|p=34302327|t=2021. Comparison of Clinical Features and Outcome of Dengue Fever and Multisystem Inflammatory Syndrome in Children Associated With COVID-19 (MIS-C).|pdf=|usr=}}
{{tp|p=34293483|t=2021. SARS-CoV-2 as a betacoronavirus comprises five structural proteins?|pdf=|usr=}}
{{tp|p=34271187|t=2021. Genetic and evolutionary analysis of SARS-CoV-2 circulating in the region surrounding Islamabad, Pakistan.|pdf=|usr=}}
{{tp|p=34252616|t=2021. New infections by SARS-CoV-2 variants of concern after natural infections and post-vaccination in Rio de Janeiro, Brazil.|pdf=|usr=}}
{{tp|p=34316588|t=2021. Bangladesh reported delta variant of coronavirus among its citizen: Actionable items to tackle the potential massive third wave.|pdf=|usr=}}
{{tp|p=34160788|t=2021. Detection of SARS-CoV-2 variants in India from UK returnees.|pdf=|usr=}}
{{tp|p=34174700|t=2021. Persistence assessment of SARS-CoV-2-specific IgG antibody in recovered COVID-19 individuals and its association with clinical symptoms and disease severity: A prospective longitudinal cohort study.|pdf=|usr=}}
{{tp|p=34286447|t=2021. COVID 19 disease independently predicted endothelial dysfunction measured by flow-mediated dilatation.|pdf=|usr=}}
{{tp|p=34107136|t=2021. Algorithm for the diagnosis and management of the multisystem inflammatory syndrome in children associated with COVID-19.|pdf=|usr=}}
{{tp|p=34107113|t=2021. Changes of serum IL-10, IL-1beta, IL-6, MCP-1, TNF-alpha, IP-10 and IL-4 in COVID-19 patients.|pdf=|usr=}}
{{tp|p=34209719|t=2021. New Onset of Hepatic Steatosis Post-Severe Multisystem Inflammatory Syndrome in Children (MIS-C): A Case Report.|pdf=|usr=}}
{{tp|p=34299089|t=2021. Role of Extracellular Vimentin in Cancer-Cell Functionality and Its Influence on Cell Monolayer Permeability Changes Induced by SARS-CoV-2 Receptor Binding Domain.|pdf=|usr=}}
{{tp|p=34299045|t=2021. Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion.|pdf=|usr=}}
{{tp|p=34281186|t=2021. Possible Link between SARS-CoV-2 Infection and Parkinson's Disease: The Role of Toll-Like Receptor 4.|pdf=|usr=}}
{{tp|p=34281182|t=2021. Molecular Mechanisms of Palmitic Acid Augmentation in COVID-19 Pathologies.|pdf=|usr=}}
{{tp|p=34290504|t=2021. Glycan Nanostructures of Human Coronaviruses.|pdf=|usr=}}
{{tp|p=34283611|t=2021. To Knot or Not to Knot: Multiple Conformations of the SARS-CoV-2 Frameshifting RNA Element.|pdf=|usr=}}
{{tp|p=34270232|t=2021. Free Energy Landscapes from SARS-CoV-2 Spike Glycoprotein Simulations Suggest that RBD Opening Can Be Modulated via Interactions in an Allosteric Pocket.|pdf=|usr=}}
{{tp|p=34328324|t=2021. Structural O-Glycoform Heterogeneity of the SARS-CoV-2 Spike Protein Receptor-Binding Domain Revealed by Top-Down Mass Spectrometry.|pdf=|usr=}}
{{tp|p=34177193|t=2021. Exploring AyuGenomics approach for understanding COVID-19 predisposition and progression.|pdf=|usr=}}
{{tp|p=34157282|t=2021. Effect of clinical isolate or cleavage site mutations in the SARS-CoV-2 spike protein on protein stability, cleavage, and cell-cell fusion.|pdf=|usr=}}
{{tp|p=34116654|t=2021. C-type lectins and extracellular vesicles in virus-induced NETosis.|pdf=|usr=}}
{{tp|p=34319802|t=2021. Assessment of SARS-CoV-2 Genome Sequencing: Quality Criteria and Low-Frequency Variants.|pdf=|usr=}}
{{tp|p=34232708|t=2021. Indeterminate QuantiFERON Gold Plus Results Reveal Deficient Interferon Gamma Responses in Severely Ill COVID-19 Patients.|pdf=|usr=}}
{{tp|p=34315010|t=2021. Dynamics of breast milk antibody titer in the six months following SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=34298379|t=2021. Emerging SARS-CoV-2 variant B.1.1.7 reduces neutralisation activity of antibodies against wild-type SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34312809|t=2021. Non-thyroidal illness syndrome and SARS-CoV-2-associated multisystem inflammatory syndrome in children.|pdf=|usr=}}
{{tp|p=34185312|t=2021. Long-term monitoring of the development and extinction of IgA and IgG responses to SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=34273397|t=2021. Revealing the Threat of Emerging SARS-CoV-2 Mutations to Antibody Therapies.|pdf=|usr=}}
{{tp|p=34289053|t=2021. The virological impacts of SARS-CoV-2 D614G mutation.|pdf=|usr=}}
{{tp|p=34242876|t=2021. Energetic and structural basis for the differences in infectivity between the wild-type and mutant spike proteins of SARS-CoV-2 in the Mexican population.|pdf=|usr=}}
{{tp|p=34255304|t=2021. SARS-CoV-2 Infection and Racial Disparities in Children: Protective Mechanisms and Severe Complications Related to MIS-C.|pdf=|usr=}}
{{tp|p=34192291|t=2021. Phlegmonous Ileocolitis as a Presentation of Post SARS-CoV-2 (COVID-19) Multisystem Inflammatory Syndrome in Children.|pdf=|usr=}}
{{tp|p=34248243|t=2021. Delta to dominate world.|pdf=|usr=}}
{{tp|p=34222663|t=2021. T cell epitopes of SARS-CoV-2 spike protein and conserved surface protein of Plasmodium malariae share sequence homology.|pdf=|usr=}}
{{tp|p=34265172|t=2021. Oxidant and antioxidant balance in patients with COVID-19.|pdf=|usr=}}
{{tp|p=34252080|t=2021. Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies.|pdf=|usr=}}
{{tp|p=34237054|t=2021. The interplay of SARS-CoV-2 evolution and constraints imposed by the structure and functionality of its proteins.|pdf=|usr=}}
{{tp|p=34228725|t=2021. SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants.|pdf=|usr=}}
{{tp|p=34280196|t=2021. Short Report: Early genomic detection of SARS-CoV-2 P.1 variant in Northeast Brazil.|pdf=|usr=}}
{{tp|p=34237072|t=2021. Prevalence of neutralising antibodies against SARS-CoV-2 in acute infection and convalescence: A systematic review and meta-analysis.|pdf=|usr=}}
{{tp|p=34324605|t=2021. Modeling neutral viral mutations in the spread of SARS-CoV-2 epidemics.|pdf=|usr=}}
{{tp|p=34259777|t=2021. Comments on "Kawasaki and COVID-19 disease in children: a systematic review".|pdf=|usr=}}
{{tp|p=34140530|t=2021. Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study.|pdf=|usr=}}
{{tp|p=34189404|t=2021. SARS-CoV2 Related Multi System Inflammatory Syndrome in a Child with Chronic Kidney Disease: Case Report.|pdf=|usr=}}
{{tp|p=34254052|t=2021. "Authors' Reply: Emerging Evidence on Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection".|pdf=|usr=}}
{{tp|p=34250445|t=2021. Comment on: Emerging Evidence on Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection.|pdf=|usr=}}
{{tp|p=34308376|t=2021. SARS-CoV-2 spike linear epitope scanning via a peptide microarray through sera profiling.|pdf=|usr=}}
{{tp|p=34221480|t=2021. SARS-CoV-2-related Multisystem Inflammatory Syndrome in Children: A case series.|pdf=|usr=}}
{{tp|p=34177422|t=2021. Neutralizing Antibodies against SARS-CoV-2 and HLA Class I and II Polymorphism.|pdf=|usr=}}
{{tp|p=34280534|t=2021. First detection of SARS-CoV-2 A.23.1 sub-lineage in migrants arriving to Italy via the Mediterranean Sea and public health implications.|pdf=|usr=}}
{{tp|p=34187722|t=2021. Cell entry by SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34229912|t=2021. Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses: (Trends in Microbiology, 29, 648-662, 2021).|pdf=|usr=}}
{{tp|p=34151202|t=2021. Identification of Novel MicroRNAs Targeting SARS-CoV-2 through the Regulation of TMPRSS2/PI3K/AKT/PTEN Alignment in Lung Cancer: An in Silico Analysis.|pdf=|usr=}}
{{tp|p=34152944|t=2021. Different long-term avidity maturation for IgG anti-spike and anti-nucleocapsid SARS-CoV-2 in hospitalized COVID-19 patients.|pdf=|usr=}}
{{tp|p=34279825|t=2021. Genetic Aspects and Immune Responses in Covid-19: Important Organ Involvement.|pdf=|usr=}}
{{tp|p=34284575|t=2021. Comprehensive O-Glycosylation Analysis of the SARS-CoV-2 Spike Protein with Biomimetic Trp-Arg Materials.|pdf=|usr=}}
{{tp|p=34261329|t=2021. Inflammasome Activation in Children With Kawasaki Disease and Multisystem Inflammatory Syndrome.|pdf=|usr=}}
{{tp|p=34124300|t=2021. Computational Analysis and Phylogenetic Clustering of SARS-CoV-2 Genomes.|pdf=|usr=}}
{{tp|p=34154997|t=2021. Covid-19: Cases of delta variant rise by 79%, but rate of growth slows.|pdf=|usr=}}
{{tp|p=34224431|t=2021. Protein S: function, regulation, and clinical perspectives.|pdf=|usr=}}
{{tp|p=34227577|t=2021. Cholesterol 25-hydroxylase expression following immune activation in response to SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=34261116|t=2021. Clinical features of multisystem inflammatory syndrome in children.|pdf=|usr=}}
{{tp|p=34232536|t=2021. Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis.|pdf=|usr=}}
{{tp|p=34328182|t=2021. Roles of steroid receptors in the lung and COVID-19.|pdf=|usr=}}
{{tp|p=34136915|t=2021. Regression of coronary arteries aneurysms 6 months after multisystem inflammatory syndrome in children (MIS-C).|pdf=|usr=}}
{{tp|p=34237522|t=2021. Dysphonia and dysphagia consequences of paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS).|pdf=|usr=}}
{{tp|p=34241335|t=2021. The role of the envelope protein in the stability of a coronavirus model membrane against an ethanolic disinfectant.|pdf=|usr=}}
{{tp|p=34263708|t=2021. Human microRNA hsa-miR-15b-5p targets the RNA template component of the RNA-dependent RNA polymerase structure in severe acute respiratory syndrome coronavirus 2.|pdf=|usr=}}
{{tp|p=34250968|t=2021. Longitudinal Follow-up of Antibody Responses in Pediatric Patients With COVID-19 up to 9 Months After Infection.|pdf=|usr=}}
{{tp|p=34227711|t=2021. Multisystem inflammatory syndrome in children: A single-center experience.|pdf=|usr=}}
{{tp|p=34219413|t=2021. EVALI versus MIS-C, one more overlapping diagnosis to consider.|pdf=|usr=}}
{{tp|p=34293253|t=2021. Cytokine storm syndrome in a young patient with cystic fibrosis.|pdf=|usr=}}
{{tp|p=34260328|t=2021. Platelet-leukocyte interactions in the pathogenesis of viral infections.|pdf=|usr=}}
{{tp|p=34168071|t=2021. Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity.|pdf=|usr=}}
{{tp|p=34168070|t=2021. Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants.|pdf=|usr=}}
{{tp|p=34172701|t=2021. Potential severe pediatric SARS-CoV-2-induced multisystem inflammatory syndrome resembles dengue infection.|pdf=|usr=}}
{{tp|p=34101517|t=2021. An Overview About the Role of Adaptive Immunity in Keeping SARS-CoV-2 Reinfections at Bay.|pdf=|usr=}}
{{tp|p=34304428|t=2021. [Expressions of MPV, P-LCR and NLR in patients with novel coronavirus disease 2019].|pdf=|usr=}}

{{tp|p=34452902|t=2021. Letter to the Editor: Morphoproteomics Confirms the Expression of Fatty Acid Synthase (FAS) in Reactive Alveolar Pneumocytes in a COVID-19 Victim: Biological and Therapeutic Implications.|pdf=|usr=}}
{{tp|p=34437814|t=2021. COVID-19: Inflammatory Profile.|pdf=|usr=}}
{{tp|p=34293954|t=2021. Re: "COVID-19: A Redox Disease-What a Stress Pandemic Can Teach Us About Resilience and What We May Learn from the Reactive Species Interactome About Its Treatment" by Cumpstey et al.|pdf=|usr=}}
{{tp|p=34269622|t=2021. Response to Verd and Verd Re: "COVID-19: A Redox Disease-What a Stress Pandemic Can Teach Us About Resilience and What We May Learn from the Reactive Species Interactome About Its Treatment".|pdf=|usr=}}
{{tp|p=34348482|t=2021. The MAVS Immune Recognition Pathway in Viral Infection and Sepsis.|pdf=|usr=}}
{{tp|p=34213801|t=2021. Does chronic inflammation cause acute inflammation to spiral into hyper-inflammation in a manner modulated by diet and the gut microbiome, in severe Covid-19?|pdf=|usr=}}
{{tp|p=34406356|t=2021. coronaSPAdes: from biosynthetic gene clusters to RNA viral assemblies.|pdf=|usr=}}
{{tp|p=34231935|t=2021. Identification of HLA-A2 restricted CD8(+) T cell epitopes in SARS-CoV-2 structural proteins.|pdf=|usr=}}
{{tp|p=34232823|t=2021. The blood-gas barrier in COVID-19: an overview of the effects of SARS-CoV-2 infection on the alveolar epithelial and endothelial cells of the lung.|pdf=|usr=}}

{{tp|p=34431626|t=2021. Performance of Cytokine Storm Syndrome Scoring Systems in Pediatric COVID-19 and Multisystem Inflammatory Syndrome in Children.|pdf=|usr=}}
{{tp|p=34235261|t=2021. Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34341769|t=2021. CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34328734|t=2021. The SARS-CoV-2 Programmed -1 Ribosomal Frameshifting Element Crystal Structure Solved to 2.09 A Using Chaperone-Assisted RNA Crystallography.|pdf=|usr=}}
{{tp|p=34437808|t=2021. Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease.|pdf=|usr=}}
{{tp|p=34319698|t=2021. Reproducible Breath Metabolite Changes in Children with SARS-CoV-2 Infection.|pdf=|usr=}}
{{tp|p=34337269|t=2021. Conformational Variability Correlation Prediction of Transmissibility and Neutralization Escape Ability for Multiple Mutation SARS-CoV-2 Strains using SSSCPreds.|pdf=|usr=}}
{{tp|p=34430559|t=2021. Analysis of the dynamic relationship between immune profiles and the clinical features of patients with COVID-19.|pdf=|usr=}}
{{tp|p=34410443|t=2021. Identification and characterization of mutations in the SARS-CoV-2 RNA-dependent RNA polymerase as a promising antiviral therapeutic target.|pdf=|usr=}}
{{tp|p=34258664|t=2021. Evolutionary insights into the furin cleavage sites of SARS-CoV-2 variants from humans and animals.|pdf=|usr=}}
{{tp|p=34322866|t=2021. First direct human-to-cat transmission of the SARS-CoV-2 B.1.1.7 variant.|pdf=|usr=}}
{{tp|p=34281462|t=2021. Manipulation of autophagy by SARS-CoV-2 proteins.|pdf=|usr=}}
{{tp|p=34303694|t=2021. Differential mutation profile of SARS-CoV-2 proteins across deceased and asymptomatic patients.|pdf=|usr=}}
{{tp|p=34284028|t=2021. Computational analysis of TMPRSS2 expression in normal and SARS-CoV-2-infected human tissues.|pdf=|usr=}}
{{tp|p=34276947|t=2021. Determination of intermediate state structures in the opening pathway of SARS-CoV-2 spike using cryo-electron microscopy.|pdf=|usr=}}
{{tp|p=34265150|t=2021. Hidden in Plain Sight: Natural Products of Commensal Microbiota as an Environmental Selection Pressure for the Rise of New Variants of SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34245743|t=2021. IL-33 Depletion in COVID-19 Lungs.|pdf=|usr=}}
{{tp|p=34208141|t=2021. The Role of Therapeutic Plasma Exchange (TPE) in Multisystem Inflammatory Syndrome in Children (MIS-C).|pdf=|usr=}}
{{tp|p=34327082|t=2021. Late-Onset COVID-19-Related Multi-System Inflammatory Syndrome in a Middle-Aged Man.|pdf=|usr=}}
{{tp|p=34306850|t=2021. The Perfect Cytokine Storm: Utilization of Lung Ultrasound During Urgent Surgery in an Infant With Multisystem Inflammatory Syndrome in Children and Hemophagocytic Lymphohistiocytosis.|pdf=|usr=}}
{{tp|p=34311326|t=2021. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.|pdf=|usr=}}
{{tp|p=34222846|t=2021. Centenarians and extremely old people living with frailty can elicit durable SARS-CoV-2 spike specific IgG antibodies with virus neutralization functions following virus infection as determined by serological study.|pdf=|usr=}}
{{tp|p=34325753|t=2021. Phylogenetic analysis of SARS-CoV-2 lineage development across the first and second waves in Eastern Germany in 2020: insights into the cause of the second wave.|pdf=|usr=}}
{{tp|p=34212240|t=2021. Investigation of endothelial dysfunction and arterial stiffness in multisystem inflammatory syndrome in children.|pdf=|usr=}}
{{tp|p=34303662|t=2021. SARS-CoV-2 attenuates corticosteroid sensitivity by suppressing DUSP1 expression and activating p38 MAPK pathway.|pdf=|usr=}}
{{tp|p=34267671|t=2021. How and to What Extent Immunological Responses to SARS-CoV-2 Shape Pulmonary Function in COVID-19 Patients.|pdf=|usr=}}
{{tp|p=34304938|t=2021. Soluble HLA-G is upregulated in serum of patients with severe COVID-19.|pdf=|usr=}}
{{tp|p=34209788|t=2021. Does the SARS-CoV-2 Spike Protein Receptor Binding Domain Interact Effectively with the DPP4 (CD26) Receptor? A Molecular Docking Study.|pdf=|usr=}}
{{tp|p=34201415|t=2021. Do Changes in ACE-2 Expression Affect SARS-CoV-2 Virulence and Related Complications: A Closer Look into Membrane-Bound and Soluble Forms.|pdf=|usr=}}
{{tp|p=34205487|t=2021. Inflammatory Mechanisms in COVID-19 and Atherosclerosis: Current Pharmaceutical Perspectives.|pdf=|usr=}}
{{tp|p=34215960|t=2021. Peripheral blood natural killer cell depletion is associated with severe pneumonia in coronavirus disease-2019 (COVID-19).|pdf=|usr=}}
{{tp|p=34225441|t=2021. ORF8 382 Mutation: A Possible Viral Prognostic Biomarker for the Severity of the COVID-19.|pdf=|usr=}}
{{tp|p=34308298|t=2021. Multi-omics analysis of respiratory specimen characterizes baseline molecular determinants associated with SARS-CoV-2 outcome.|pdf=|usr=}}
{{tp|p=34308276|t=2021. Sensor array and gas chromatographic detection of the blood serum volatolomic signature of COVID-19.|pdf=|usr=}}
{{tp|p=34329427|t=2021. SARS-CoV-2 Antibodies and Associated Factors at Different Hospitalization Time Points in 192 COVID-19 Cases.|pdf=|usr=}}
{{tp|p=34209269|t=2021. Ocular and Systemic Manifestations in Paediatric Multisystem Inflammatory Syndrome Associated with COVID-19.|pdf=|usr=}}
{{tp|p=34196431|t=2021. SARS-CoV-2 virulence evolution: Avirulence theory, immunity and trade-offs.|pdf=|usr=}}
{{tp|p=34329486|t=2021. A cluster of the new SARS-CoV-2 B.1.621 lineage in Italy and sensitivity of the viral isolate to the BNT162b2 vaccine.|pdf=|usr=}}
{{tp|p=34314050|t=2021. SARS-CoV-2 R.1 lineage variants that prevailed in Tokyo in March 2021.|pdf=|usr=}}
{{tp|p=34314049|t=2021. Introduction of SARS-COV-2 C.37 (WHO VOI lambda) from Peru to Italy.|pdf=|usr=}}
{{tp|p=34314048|t=2021. Sequencing on an imported case in China of COVID-19 Delta variant emerging from India in a cargo ship in Zhoushan, China.|pdf=|usr=}}
{{tp|p=34292617|t=2021. Evolution trace of SARS-CoV-2 from January 19 to March 12, 2020, in the United States.|pdf=|usr=}}
{{tp|p=34260088|t=2021. SARS-CoV-2 B.1.617 Indian variants: Are electrostatic potential changes responsible for a higher transmission rate?|pdf=|usr=}}
{{tp|p=34255352|t=2021. The variants question: What is the problem?|pdf=|usr=}}
{{tp|p=34245452|t=2021. Updated SARS-CoV-2 single nucleotide variants and mortality association.|pdf=|usr=}}
{{tp|p=34241897|t=2021. Genomic monitoring unveil the early detection of the SARS-CoV-2 B.1.351 (beta) variant (20H/501Y.V2) in Brazil.|pdf=|usr=}}
{{tp|p=34193667|t=2021. Less frequent sequence mismatches in variants of concern (VOCs) of SARS-CoV-2 in the real-time RT-PCR assays developed by the National Institute of Infectious Diseases, Japan.|pdf=|usr=}}
{{tp|p=34273381|t=2021. Superior cellular and humoral immunity toward SARS-CoV-2 reference and alpha and beta VOC strains in COVID-19 convalescent as compared to the prime boost BNT162b2-vaccinated dialysis patients.|pdf=|usr=}}
{{tp|p=34197767|t=2021. The SARS-CoV-2 B.1.1.7 variant and increased clinical severity-the jury is out.|pdf=|usr=}}
{{tp|p=34278372|t=2021. Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France.|pdf=|usr=}}
{{tp|p=34278371|t=2021. Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany.|pdf=|usr=}}
{{tp|p=34292071|t=2021. Genomic Surveillance of SARS-CoV-2 Viruses Collected during the Ending Phase of the First Wave of the COVID-19 Pandemic in Bangladesh.|pdf=|usr=}}
{{tp|p=34264104|t=2021. Coding-Complete Genome Sequences of 11 SARS-CoV-2 B.1.1.7 and B.1.351 Variants from Metro Manila, Philippines.|pdf=|usr=}}
{{tp|p=34264100|t=2021. Genome Sequences of 15 SARS-CoV-2 Sublineage B.1.617.2 Strains in Bangladesh.|pdf=|usr=}}
{{tp|p=34197207|t=2021. New SARS-CoV-2 Variant from Jordan.|pdf=|usr=}}
{{tp|p=34287058|t=2021. Durable Antibody Responses in Staff at Two Long-Term Care Facilities, during and Post SARS-CoV-2 Outbreaks.|pdf=|usr=}}
{{tp|p=34200249|t=2021. Reversion of Gut Microbiota during the Recovery Phase in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study.|pdf=|usr=}}
{{tp|p=34203277|t=2021. Multisystem Inflammatory Syndrome in an Adult (MIS-A) Successfully Treated with Anakinra and Glucocorticoids.|pdf=|usr=}}
{{tp|p=34203929|t=2021. Dose-Related Aberrant Inhibition of Intracellular Perforin Expression by S1 Subunit of Spike Glycoprotein That Contains Receptor-Binding Domain from SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34193870|t=2021. SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells.|pdf=|usr=}}
{{tp|p=34234119|t=2021. The molecular basis for SARS-CoV-2 binding to dog ACE2.|pdf=|usr=}}
{{tp|p=34230476|t=2021. Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan.|pdf=|usr=}}
{{tp|p=34226537|t=2021. Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.|pdf=|usr=}}
{{tp|p=34326343|t=2021. SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection.|pdf=|usr=}}
{{tp|p=34326336|t=2021. Endogenous control of inflammation characterizes pregnant women with asymptomatic or paucisymptomatic SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=34321474|t=2021. IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro.|pdf=|usr=}}
{{tp|p=34315903|t=2021. Integrative genomic analyses identify susceptibility genes underlying COVID-19 hospitalization.|pdf=|usr=}}
{{tp|p=34315893|t=2021. Single-cell transcriptome of bronchoalveolar lavage fluid reveals sequential change of macrophages during SARS-CoV-2 infection in ferrets.|pdf=|usr=}}
{{tp|p=34315889|t=2021. The trans-omics landscape of COVID-19.|pdf=|usr=}}
{{tp|p=34199224|t=2021. Is SARS-CoV-2 Neutralized More Effectively by IgM and IgA than IgG Having the Same Fab Region?|pdf=|usr=}}
{{tp|p=34297786|t=2021. SARS-CoV-2 variant evolution in the United States: High accumulation of viral mutations over time likely through serial Founder Events and mutational bursts.|pdf=|usr=}}
{{tp|p=34214116|t=2021. Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=34320031|t=2021. Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=34280244|t=2021. Early antibody responses associated with survival in COVID19 patients.|pdf=|usr=}}
{{tp|p=34270631|t=2021. SARS-CoV-2-specific circulating T follicular helper cells correlate with neutralizing antibodies and increase during early convalescence.|pdf=|usr=}}
{{tp|p=34270613|t=2021. Mutants of human ACE2 differentially promote SARS-CoV and SARS-CoV-2 spike mediated infection.|pdf=|usr=}}
{{tp|p=34260666|t=2021. COVID-19 virtual patient cohort suggests immune mechanisms driving disease outcomes.|pdf=|usr=}}
{{tp|p=34259880|t=2021. Short-term outcomes in children recovered from multisystem inflammatory syndrome associated with SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=34315815|t=2021. SARS-CoV-2 infection triggers widespread host mRNA decay leading to an mRNA export block.|pdf=|usr=}}
{{tp|p=34248311|t=2021. Genetic Control of Human Infection with SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34188167|t=2021. Activation of NF-kappaB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34238985|t=2021. In vitro Interleukin-7 treatment partially rescues MAIT cell dysfunction caused by SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=34234167|t=2021. Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.|pdf=|usr=}}
{{tp|p=34226622|t=2021. Understanding protection from SARS-CoV-2 using metabolomics.|pdf=|usr=}}
{{tp|p=34312429|t=2021. S494 O-glycosylation site on the SARS-CoV-2 RBD affects the virus affinity to ACE2 and its infectivity; a molecular dynamics study.|pdf=|usr=}}
{{tp|p=34217923|t=2021. Insilico study on the effect of SARS-CoV-2 RBD hotspot mutants' interaction with ACE2 to understand the binding affinity and stability.|pdf=|usr=}}
{{tp|p=34325286|t=2021. SARS-CoV-2 and other coronaviruses bind to phosphorylated glycans from the human lung.|pdf=|usr=}}
{{tp|p=34265628|t=2021. Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.|pdf=|usr=}}
{{tp|p=34320912|t=2021. COVID-19 adaptive evolution during the pandemic - Implications of new SARS-CoV-2 variants on public health policies.|pdf=|usr=}}
{{tp|p=34251989|t=2021. The journey of SARS-CoV-2 in human hosts: a review of immune responses, immunosuppression, and their consequences.|pdf=|usr=}}
{{tp|p=34251592|t=2021. Temporal landscape of mutational frequencies in SARS-CoV-2 genomes of Bangladesh: possible implications from the ongoing outbreak in Bangladesh.|pdf=|usr=}}
{{tp|p=34314772|t=2021. Structural modelling of SARS-CoV-2 alpha variant (B.1.1.7) suggests enhanced furin binding and infectivity.|pdf=|usr=}}
{{tp|p=34329696|t=2021. SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects.|pdf=|usr=}}
{{tp|p=34207696|t=2021. HERC5 and the ISGylation Pathway: Critical Modulators of the Antiviral Immune Response.|pdf=|usr=}}
{{tp|p=34207490|t=2021. A Comprehensive Molecular Epidemiological Analysis of SARS-CoV-2 Infection in Cyprus from April 2020 to January 2021: Evidence of a Highly Polyphyletic and Evolving Epidemic.|pdf=|usr=}}
{{tp|p=34200386|t=2021. Replication Kinetics of B.1.351 and B.1.1.7 SARS-CoV-2 Variants of Concern Including Assessment of a B.1.1.7 Mutant Carrying a Defective ORF7a Gene.|pdf=|usr=}}
{{tp|p=34205098|t=2021. The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner.|pdf=|usr=}}
{{tp|p=34209881|t=2021. Modular Evolution of Coronavirus Genomes.|pdf=|usr=}}
{{tp|p=34199077|t=2021. From Recoding to Peptides for MHC Class I Immune Display: Enriching Viral Expression, Virus Vulnerability and Virus Evasion.|pdf=|usr=}}
{{tp|p=34206990|t=2021. Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry.|pdf=|usr=}}
{{tp|p=34202160|t=2021. Modulation of Viral Programmed Ribosomal Frameshifting and Stop Codon Readthrough by the Host Restriction Factor Shiftless.|pdf=|usr=}}
{{tp|p=34202098|t=2021. How Do Enveloped Viruses Exploit the Secretory Proprotein Convertases to Regulate Infectivity and Spread?|pdf=|usr=}}
{{tp|p=34200602|t=2021. The SARS-CoV-2 Nucleocapsid Protein and Its Role in Viral Structure, Biological Functions, and a Potential Target for Drug or Vaccine Mitigation.|pdf=|usr=}}
{{tp|p=34452902|t=2021. Letter to the Editor: Morphoproteomics Confirms the Expression of Fatty Acid Synthase (FAS) in Reactive Alveolar Pneumocytes in a COVID-19 Victim: Biological and Therapeutic Implications.|pdf=|usr=}}
{{tp|p=34437814|t=2021. COVID-19: Inflammatory Profile.|pdf=|usr=}}
{{tp|p=34293954|t=2021. Re: "COVID-19: A Redox Disease-What a Stress Pandemic Can Teach Us About Resilience and What We May Learn from the Reactive Species Interactome About Its Treatment" by Cumpstey et al.|pdf=|usr=}}
{{tp|p=34269622|t=2021. Response to Verd and Verd Re: "COVID-19: A Redox Disease-What a Stress Pandemic Can Teach Us About Resilience and What We May Learn from the Reactive Species Interactome About Its Treatment".|pdf=|usr=}}
{{tp|p=34348482|t=2021. The MAVS Immune Recognition Pathway in Viral Infection and Sepsis.|pdf=|usr=}}
{{tp|p=34213801|t=2021. Does chronic inflammation cause acute inflammation to spiral into hyper-inflammation in a manner modulated by diet and the gut microbiome, in severe Covid-19?|pdf=|usr=}}
{{tp|p=34406356|t=2021. coronaSPAdes: from biosynthetic gene clusters to RNA viral assemblies.|pdf=|usr=}}
{{tp|p=34231935|t=2021. Identification of HLA-A2 restricted CD8(+) T cell epitopes in SARS-CoV-2 structural proteins.|pdf=|usr=}}
{{tp|p=34232823|t=2021. The blood-gas barrier in COVID-19: an overview of the effects of SARS-CoV-2 infection on the alveolar epithelial and endothelial cells of the lung.|pdf=|usr=}}

{{tp|p=34214538|t=2021. Biophysical properties of the isolated spike protein binding helix of human ACE2.|pdf=|usr=}}
{{tp|p=34214535|t=2021. Role of spatial patterning of N-protein interactions in SARS-CoV-2 genome packaging.|pdf=|usr=}}
{{tp|p=34197807|t=2021. Regulation of epithelial sodium channel activity by SARS-CoV-1 and SARS-CoV-2 proteins.|pdf=|usr=}}
{{tp|p=34197802|t=2021. Dynamics of the SARS-CoV-2 nucleoprotein N-terminal domain triggers RNA duplex destabilization.|pdf=|usr=}}
{{tp|p=34197805|t=2021. Transient and stabilized complexes of Nsp7, Nsp8, and Nsp12 in SARS-CoV-2 replication.|pdf=|usr=}}
{{tp|p=34313294|t=2021. A lipidomic view of SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34225645|t=2021. Immune cell profiling and antibody responses in patients with COVID-19.|pdf=|usr=}}
{{tp|p=34225644|t=2021. Sex-based clinical and immunological differences in COVID-19.|pdf=|usr=}}
{{tp|p=34260684|t=2021. Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis.|pdf=|usr=}}
{{tp|p=34257504|t=2021. An outline of SARS-CoV-2 pathogenesis and the complement cascade of immune system.|pdf=|usr=}}
{{tp|p=34306789|t=2021. COVID-19 Infection in Spinal Muscular Atrophy Associated with Multisystem Inflammatory Syndrome.|pdf=|usr=}}
{{tp|p=34242577|t=2021. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies.|pdf=|usr=}}
{{tp|p=34289344|t=2021. A selective sweep in the Spike gene has driven SARS-CoV-2 human adaptation.|pdf=|usr=}}
{{tp|p=34294141|t=2021. Genome-wide analysis of protein-protein interactions and involvement of viral proteins in SARS-CoV-2 replication.|pdf=|usr=}}
{{tp|p=34246414|t=2021. SARS-COV-2 spike binding to ACE2 in living cells monitored by TR-FRET.|pdf=|usr=}}
{{tp|p=34238338|t=2021. Single-cell analysis reveals cell communication triggered by macrophages associated with the reduction and exhaustion of CD8(+) T cells in COVID-19.|pdf=|usr=}}
{{tp|p=34301919|t=2021. RBM15-mediated N6-methyladenosine modification affects COVID-19 severity by regulating the expression of multitarget genes.|pdf=|usr=}}
{{tp|p=34226505|t=2021. H-Ras gene takes part to the host immune response to COVID-19.|pdf=|usr=}}
{{tp|p=34315869|t=2021. ScRNA-seq revealed the kinetic of nasopharyngeal immune responses in asymptomatic COVID-19 carriers.|pdf=|usr=}}
{{tp|p=34265243|t=2021. An aberrant inflammatory response in severe COVID-19.|pdf=|usr=}}
{{tp|p=34265239|t=2021. Virus hunters: Discovering the evolutionary origins of SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34242582|t=2021. HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens.|pdf=|usr=}}
{{tp|p=34237248|t=2021. SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19.|pdf=|usr=}}
{{tp|p=34216827|t=2021. Gut ACE2 Expression, Tryptophan Deficiency, and Inflammatory Responses The Potential Connection That Should Not Be Ignored During SARS-CoV-2 Infection.|pdf=|usr=}}
{{tp|p=34321622|t=2021. Increase in serum levels of phosphatidylserine-specific phospholipase A1 in COVID-19 patients.|pdf=|usr=}}
{{tp|p=34290398|t=2021. Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=34223911|t=2021. Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs.|pdf=|usr=}}
{{tp|p=34270919|t=2021. SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination.|pdf=|usr=}}
{{tp|p=34260965|t=2021. Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19.|pdf=|usr=}}
{{tp|p=34242574|t=2021. Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteins.|pdf=|usr=}}
{{tp|p=34272947|t=2021. An Update on SARS-CoV-2 Diversity in the United States National Capital Region: Evolution of Novel and Variants of Concern.|pdf=|usr=}}
{{tp|p=34221376|t=2021. Potential resistance to SARS-CoV-2 infection in lysosomal storage disorders.|pdf=|usr=}}
{{tp|p=34221375|t=2021. Genes, COVID-19 and phenotype.|pdf=|usr=}}
{{tp|p=34253247|t=2021. Emerging SARS-CoV-2 variants of concern and potential intervention approaches.|pdf=|usr=}}
{{tp|p=34328076|t=2021. An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) in a secondary care hospital in Finland, May 2021.|pdf=|usr=}}
{{tp|p=34328074|t=2021. Vaccine breakthrough infection and onward transmission of SARS-CoV-2 Beta (B.1.351) variant, Bavaria, Germany, February to March 2021.|pdf=|usr=}}
{{tp|p=34269174|t=2021. Rapid spread of the SARS-CoV-2 Delta variant in some French regions, June 2021.|pdf=|usr=}}
{{tp|p=34240695|t=2021. Predicted dominance of variant Delta of SARS-CoV-2 before Tokyo Olympic Games, Japan, July 2021.|pdf=|usr=}}
{{tp|p=34290742|t=2021. Identification of Causal Genes of COVID-19 Using the SMR Method.|pdf=|usr=}}
{{tp|p=34211506|t=2021. COVID-19 and SARS-CoV-2 Variants: Current Challenges and Health Concern.|pdf=|usr=}}
{{tp|p=34326844|t=2021. Impaired Priming of SARS-CoV-2-Specific Naive CD8(+) T Cells in Older Subjects.|pdf=|usr=}}
{{tp|p=34326843|t=2021. The Many Faces of JAKs and STATs Within the COVID-19 Storm.|pdf=|usr=}}
{{tp|p=34322127|t=2021. A Single-Cell Atlas of Lymphocyte Adaptive Immune Repertoires and Transcriptomes Reveals Age-Related Differences in Convalescent COVID-19 Patients.|pdf=|usr=}}
{{tp|p=34322120|t=2021. Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology.|pdf=|usr=}}
{{tp|p=34305949|t=2021. SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns.|pdf=|usr=}}
{{tp|p=34305903|t=2021. ROS/RNS Balancing, Aerobic Fermentation Regulation and Cell Cycle Control - a Complex Early Trait ('CoV-MAC-TED') for Combating SARS-CoV-2-Induced Cell Reprogramming.|pdf=|usr=}}
{{tp|p=34305895|t=2021. Low Innate Immunity and Lagged Adaptive Immune Response in the Re-Tested Viral RNA Positivity of a COVID-19 Patient.|pdf=|usr=}}
{{tp|p=34305894|t=2021. The Spike of SARS-CoV-2: Uniqueness and Applications.|pdf=|usr=}}
{{tp|p=34305888|t=2021. Identification of the SARS-CoV-2 Entry Receptor ACE2 as a Direct Target for Transcriptional Repression by Miz1.|pdf=|usr=}}
{{tp|p=34290717|t=2021. Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins.|pdf=|usr=}}
{{tp|p=34276680|t=2021. AID and APOBECs as Multifaceted Intrinsic Virus-Restricting Factors: Emerging Concepts in the Light of COVID-19.|pdf=|usr=}}
{{tp|p=34276672|t=2021. Enhanced Expression of Autoantigens During SARS-CoV-2 Viral Infection.|pdf=|usr=}}
{{tp|p=34267764|t=2021. Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.|pdf=|usr=}}
{{tp|p=34262555|t=2021. Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients.|pdf=|usr=}}
{{tp|p=34249006|t=2021. RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses.|pdf=|usr=}}
{{tp|p=34248984|t=2021. Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.|pdf=|usr=}}
{{tp|p=34248968|t=2021. SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages.|pdf=|usr=}}
{{tp|p=34248962|t=2021. Case Report: Adult Post-COVID-19 Multisystem Inflammatory Syndrome and Thrombotic Microangiopathy.|pdf=|usr=}}
{{tp|p=34248940|t=2021. Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism.|pdf=|usr=}}
{{tp|p=34234779|t=2021. Elevated Interleukin-10 Levels in COVID-19: Potentiation of Pro-Inflammatory Responses or Impaired Anti-Inflammatory Action?|pdf=|usr=}}
{{tp|p=34220870|t=2021. Declining Levels of Neutralizing Antibodies Against SARS-CoV-2 in Convalescent COVID-19 Patients One Year Post Symptom Onset.|pdf=|usr=}}
{{tp|p=34220859|t=2021. Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19.|pdf=|usr=}}
{{tp|p=34220846|t=2021. A Comparative Analysis of Coronavirus Nucleocapsid (N) Proteins Reveals the SADS-CoV N Protein Antagonizes IFN-beta Production by Inducing Ubiquitination of RIG-I.|pdf=|usr=}}
{{tp|p=34220844|t=2021. The Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom.|pdf=|usr=}}
{{tp|p=34211469|t=2021. Cross-Reactive SARS-CoV-2 Neutralizing Antibodies From Deep Mining of Early Patient Responses.|pdf=|usr=}}
{{tp|p=34194438|t=2021. Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.|pdf=|usr=}}
{{tp|p=34194429|t=2021. Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis.|pdf=|usr=}}
{{tp|p=34239886|t=2021. SARS-CoV-2 Viral Shedding and Transmission Dynamics: Implications of WHO COVID-19 Discharge Guidelines.|pdf=|usr=}}
{{tp|p=34239884|t=2021. Severe Clinical Worsening in COVID-19 and Potential Mechanisms of Immune-Enhanced Disease.|pdf=|usr=}}
{{tp|p=34222275|t=2021. Persisting Antibody Response to SARS-CoV-2 in a Local Austrian Population.|pdf=|usr=}}
{{tp|p=34229864|t=2021. Humoral immune mechanisms involved in protective and pathological immunity during COVID-19.|pdf=|usr=}}
{{tp|p=34273395|t=2021. Distinctive pseudopalisaded histiocytic hyperplasia characterizes the transition of exudative to proliferative phase of diffuse alveolar damage in patients dying of COVID-19.|pdf=|usr=}}
{{tp|p=34230877|t=2021. Red face may be a specific sign of SARS-CoV-2 alpha variant.|pdf=|usr=}}
{{tp|p=34231951|t=2021. A macrophage attack culminating in microthromboses characterizes COVID 19 pneumonia.|pdf=|usr=}}
{{tp|p=34246326|t=2021. Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants.|pdf=|usr=}}
{{tp|p=34228987|t=2021. SARS-CoV-2 Spike protein enhances ACE2 expression via facilitating Interferon effects in bronchial epithelium.|pdf=|usr=}}
{{tp|p=34292476|t=2021. Humoral immune durability of IgG for anti-SARS-CoV-2 in the normal pregnant women in Wuhan, China.|pdf=|usr=}}
{{tp|p=34202646|t=2021. Virus-Negative Necrotizing Coronary Vasculitis with Aneurysm Formation in Human SARS-CoV-2 Infection.|pdf=|usr=}}
{{tp|p=34267528|t=2021. Detection of Representative Mutant Strains and a Case of Prolonged Infection by SARS-CoV-2 with Spike 69/70 Deletion in Japan.|pdf=|usr=}}
{{tp|p=34271202|t=2021. Monoclonal Antibody Therapy in a Vaccine Breakthrough SARS-CoV-2 Hospitalized Delta (B.1.617.2) Variant Case.|pdf=|usr=}}
{{tp|p=34273512|t=2021. Immunity against seasonal human coronavirus OC43 mitigates fatal deterioration of COVID-19.|pdf=|usr=}}
{{tp|p=34260956|t=2021. High seroprevalence for SARS-CoV-2 infection in South America, but still not enough for herd immunity!|pdf=|usr=}}
{{tp|p=34209845|t=2021. Innate Immune Response to SARS-CoV-2 Infection: From Cells to Soluble Mediators.|pdf=|usr=}}
{{tp|p=34193364|t=2021. Innate immune response analysis in COVID-19 and kawasaki disease reveals MIS-C predictors.|pdf=|usr=}}
{{tp|p=34285538|t=2021. Prevalence and Characteristics of Rheumatoid-Associated Autoantibodies in Patients with COVID-19.|pdf=|usr=}}
{{tp|p=34319496|t=2021. The potential role of neopterin in Covid-19: a new perspective.|pdf=|usr=}}
{{tp|p=34242919|t=2021. Untangling COVID-19 and autoimmunity: Identification of plausible targets suggests multi organ involvement.|pdf=|usr=}}
{{tp|p=34254040|t=2021. Comparative Analysis of Emerging B.1.1.7+E484K SARS-CoV-2 Isolates.|pdf=|usr=}}
{{tp|p=34224908|t=2021. SARS-CoV-2 infection and parasitic diseases: A possible role for microbiome interaction?|pdf=|usr=}}
{{tp|p=34199852|t=2021. Long-Term Persistence of Anti-SARS-CoV-2 Antibodies in a Pediatric Population.|pdf=|usr=}}
{{tp|p=34201967|t=2021. Study of the Plasma and Buffy Coat in Patients with SARS-CoV-2 Infection-A Preliminary Report.|pdf=|usr=}}
{{tp|p=34288921|t=2021. Molecular epidemiology of SARS-CoV-2 in Cyprus.|pdf=|usr=}}
{{tp|p=34211037|t=2021. The RNA sensor MDA5 detects SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=34210996|t=2021. Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant.|pdf=|usr=}}
{{tp|p=34230210|t=2021. Kynurenic acid may underlie sex-specific immune responses to COVID-19.|pdf=|usr=}}
{{tp|p=34201088|t=2021. A Unique SARS-CoV-2 Spike Protein P681H Variant Detected in Israel.|pdf=|usr=}}
{{tp|p=34199761|t=2021. The Many Faces of Innate Immunity in SARS-CoV-2 Infection.|pdf=|usr=}}
{{tp|p=34202276|t=2021. Development of SARS-CoV-2 Specific IgG and Virus-Neutralizing Antibodies after Infection with Variants of Concern or Vaccination.|pdf=|usr=}}
{{tp|p=34199357|t=2021. Titers, Prevalence, and Duration of SARS-CoV-2 Antibodies in a Local COVID-19 Outbreak and Following Vaccination.|pdf=|usr=}}
{{tp|p=34276267|t=2021. Variantes de SARS-CoV-2, una historia todavia inacabada.|pdf=|usr=}}
{{tp|p=34275492|t=2021. SARS-CoV-2: preliminary study of infected human nasopharyngeal tissue by high resolution microscopy.|pdf=|usr=}}
{{tp|p=34201767|t=2021. SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies.|pdf=|usr=}}
{{tp|p=34206453|t=2021. Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?|pdf=|usr=}}
{{tp|p=34205489|t=2021. Broad Impact of Exchange Protein Directly Activated by cAMP 2 (EPAC2) on Respiratory Viral Infections.|pdf=|usr=}}
{{tp|p=34198530|t=2021. Modeling within-Host SARS-CoV-2 Infection Dynamics and Potential Treatments.|pdf=|usr=}}
{{tp|p=34199223|t=2021. Functions of Coronavirus Accessory Proteins: Overview of the State of the Art.|pdf=|usr=}}
{{tp|p=34204754|t=2021. Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals.|pdf=|usr=}}
{{tp|p=34204732|t=2021. Different Neutralization Sensitivity of SARS-CoV-2 Cell-to-Cell and Cell-Free Modes of Infection to Convalescent Sera.|pdf=|usr=}}
{{tp|p=34208191|t=2021. Full-Length Computational Model of the SARS-CoV-2 Spike Protein and Its Implications for a Viral Membrane Fusion Mechanism.|pdf=|usr=}}
{{tp|p=34340962|t=2021. Covid-19: Delta infections threaten herd immunity vaccine strategy.|pdf=|usr=}}
{{tp|p=34413059|t=2021. Covid-19: How many variants are there, and what do we know about them?|pdf=|usr=}}
{{tp|p=34413020|t=2021. Covid-19: Fully vaccinated people can carry as much delta virus as unvaccinated people, data indicate.|pdf=|usr=}}

{{tp|p=34246957|t=2021. Syncope and silent hypoxemia in COVID-19: Implications for the autonomic field.|pdf=|usr=}}
{{tp|p=34224022|t=2021. Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants.|pdf=|usr=}}
{{tp|p=34246830|t=2021. Analysis of SARS-CoV-2 nucleocapsid phosphoprotein N variations in the binding site to human 14-3-3 proteins.|pdf=|usr=}}
{{tp|p=34213308|t=2021. Site-Specific Steric Control of SARS-CoV-2 Spike Glycosylation.|pdf=|usr=}}
{{tp|p=34274319|t=2021. Membranotropic and biological activities of the membrane fusion peptides from SARS-CoV spike glycoprotein: The importance of the complete internal fusion peptide domain.|pdf=|usr=}}
{{tp|p=34237472|t=2021. In silico analysis of the aggregation propensity of the SARS-CoV-2 proteome: Insight into possible cellular pathologies.|pdf=|usr=}}
{{tp|p=34220199|t=2021. Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins.|pdf=|usr=}}
{{tp|p=34234394|t=2021. Differential binding of SARS-CoV-2 Spike protein variants to its cognate receptor hACE2 using molecular modeling based binding analysis.|pdf=|usr=}}
{{tp|p=34198622|t=2021. SARS-CoV-2 Variants in Lebanon: Evolution and Current Situation.|pdf=|usr=}}
{{tp|p=34193390|t=2021. Role of SARS-CoV-2 and ACE2 variations in COVID-19.|pdf=|usr=}}
{{tp|p=34271250|t=2021. Emerging mutation in SARS-CoV-2 spike: Widening distribution over time in different geographic areas.|pdf=|usr=}}
{{tp|p=34307679|t=2021. Identifying COVID-19-Specific Transcriptomic Biomarkers with Machine Learning Methods.|pdf=|usr=}}
{{tp|p=34258267|t=2021. Relevant SARS-CoV-2 Genome Variation through Six Months of Worldwide Monitoring.|pdf=|usr=}}
{{tp|p=34202515|t=2021. Oxidative Stress and Inflammation in SARS-CoV-2- and Chlamydia pneumoniae-Associated Cardiovascular Diseases.|pdf=|usr=}}
{{tp|p=34207362|t=2021. Genome-Wide Analysis of Codon Usage Patterns of SARS-CoV-2 Virus Reveals Global Heterogeneity of COVID-19.|pdf=|usr=}}
{{tp|p=34204735|t=2021. Hyperactivated RAGE in Comorbidities as a Risk Factor for Severe COVID-19-The Role of RAGE-RAS Crosstalk.|pdf=|usr=}}
{{tp|p=34237251|t=2021. Computational methods to predict the mutational landscape of the spike protein.|pdf=|usr=}}
{{tp|p=34219983|t=2021. Atlas der SARS-CoV-2-RNA-Protein-Interaktionen in infizierten Zellen.|pdf=|usr=}}
{{tp|p=34210280|t=2021. Lymphocyte subset alterations with disease severity, imaging manifestation, and delayed hospitalization in COVID-19 patients.|pdf=|usr=}}
{{tp|p=34189273|t=2021. Mass spectrometric based detection of protein nucleotidylation in the RNA polymerase of SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34320442|t=2021. Decrypting the role of predicted SARS-CoV-2 miRNAs in COVID-19 pathogenesis: A bioinformatics approach.|pdf=|usr=}}
{{tp|p=34246161|t=2021. High-throughput analysis of the interactions between viral proteins and host cell RNAs.|pdf=|usr=}}
{{tp|p=34234921|t=2021. Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses.|pdf=|usr=}}
{{tp|p=34306570|t=2021. Exploiting the molecular basis of age and gender differences in outcomes of SARS-CoV-2 infections.|pdf=|usr=}}
{{tp|p=34217135|t=2021. Natural killer cells and unconventional T cells in COVID-19.|pdf=|usr=}}
{{tp|p=34272088|t=2021. Alterations of Lipid Profile in COVID-19: A Narrative Review.|pdf=|usr=}}
{{tp|p=34305860|t=2021. Host- and Species-Dependent Quasispecies Divergence of Severe Acute Respiratory Syndrome Coronavirus-2 in Non-human Primate Models.|pdf=|usr=}}
{{tp|p=34267735|t=2021. Meta-Analysis and Structural Dynamics of the Emergence of Genetic Variants of SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34234758|t=2021. A Novel SARS-CoV-2 Viral Sequence Bioinformatic Pipeline Has Found Genetic Evidence That the Viral 3' Untranslated Region (UTR) Is Evolving and Generating Increased Viral Diversity.|pdf=|usr=}}
{{tp|p=34220784|t=2021. The First Molecular Characterization of Serbian SARS-CoV-2 Isolates From a Unique Early Second Wave in Europe.|pdf=|usr=}}
{{tp|p=34322518|t=2021. Mathematical Model of SARS-Cov-2 Propagation Versus ACE2 Fits COVID-19 Lethality Across Age and Sex and Predicts That of SARS.|pdf=|usr=}}
{{tp|p=34274478|t=2021. No association between the SARS-CoV-2 variants and mortality rates in the Eastern Mediterranean Region.|pdf=|usr=}}
{{tp|p=34202172|t=2021. Uncovering Signals from the Coronavirus Genome.|pdf=|usr=}}
{{tp|p=34222571|t=2021. Identification of Cross-Reactive CD8(+) T Cell Receptors with High Functional Avidity to a SARS-CoV-2 Immunodominant Epitope and Its Natural Mutant Variants.|pdf=|usr=}}
{{tp|p=34228320|t=2021. Relative synonymous codon usage of ORF1ab in SARS-CoV-2 and SARS-CoV.|pdf=|usr=}}
{{tp|p=34210356|t=2021. CLIMB-COVID: continuous integration supporting decentralised sequencing for SARS-CoV-2 genomic surveillance.|pdf=|usr=}}
{{tp|p=34281603|t=2021. Single-nucleus transcriptome analysis of human brain immune response in patients with severe COVID-19.|pdf=|usr=}}
{{tp|p=34296023|t=2021. Recent advance of ACE2 and microbiota dysfunction in COVID-19 pathogenesis.|pdf=|usr=}}
{{tp|p=34207510|t=2021. Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms.|pdf=|usr=}}
{{tp|p=34200325|t=2021. Evidence for Biological Age Acceleration and Telomere Shortening in COVID-19 Survivors.|pdf=|usr=}}
{{tp|p=34198800|t=2021. In Silico and In Vitro Analyses Validate Human MicroRNAs Targeting the SARS-CoV-2 3'-UTR.|pdf=|usr=}}
{{tp|p=34207476|t=2021. Heparan Sulfate Proteoglycans in Viral Infection and Treatment: A Special Focus on SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34204305|t=2021. The Functional Consequences of the Novel Ribosomal Pausing Site in SARS-CoV-2 Spike Glycoprotein RNA.|pdf=|usr=}}
{{tp|p=34206057|t=2021. Autophagy, Unfolded Protein Response, and Neuropilin-1 Cross-Talk in SARS-CoV-2 Infection: What Can Be Learned from Other Coronaviruses.|pdf=|usr=}}
{{tp|p=34205975|t=2021. Multifaced Roles of HDL in Sepsis and SARS-CoV-2 Infection: Renal Implications.|pdf=|usr=}}
{{tp|p=34299201|t=2021. Problems of Pathogenesis and Pathogenetic Therapy of COVID-19 from the Perspective of the General Theory of Pathological Systems (General Pathological Processes).|pdf=|usr=}}
{{tp|p=34299124|t=2021. Extension of Collagen Deposition in COVID-19 Post Mortem Lung Samples and Computed Tomography Analysis Findings.|pdf=|usr=}}
{{tp|p=34299101|t=2021. COVID-19 in Children: Expressions of Type I/II/III Interferons, TRIM28, SETDB1, and Endogenous Retroviruses in Mild and Severe Cases.|pdf=|usr=}}
{{tp|p=34273582|t=2021. SARS-CoV-2 Infection in the Immunodeficient Host: Necessary and Dispensable Immune Pathways.|pdf=|usr=}}
{{tp|p=34273581|t=2021. Association of Varying Clinical Manifestations and Positive Anti-SARS-CoV-2 IgG Antibodies: A Cross-Sectional Observational Study.|pdf=|usr=}}
{{tp|p=34303083|t=2021. Durable antibody response one year after hospitalization for COVID-19: A longitudinal cohort study.|pdf=|usr=}}
{{tp|p=34223909|t=2021. Limited Neutralization of Authentic Severe Acute Respiratory Syndrome Coronavirus 2 Variants Carrying E484K In Vitro.|pdf=|usr=}}
{{tp|p=34282461|t=2021. Kinetics of the SARS-CoV-2 antibody response and serological estimation of time since infection.|pdf=|usr=}}
{{tp|p=34268819|t=2021. Self-infection with speech aerosol may contribute to COVID-19 severity.|pdf=|usr=}}
{{tp|p=34255499|t=2021. Binding of SARS-CoV-2 Fusion Peptide to Host Endosome and Plasma Membrane.|pdf=|usr=}}
{{tp|p=34328740|t=2021. Role of ATP in the RNA Translocation Mechanism of SARS-CoV-2 NSP13 Helicase.|pdf=|usr=}}
{{tp|p=34196568|t=2021. Interfacial Water Many-Body Effects Drive Structural Dynamics and Allosteric Interactions in SARS-CoV-2 Main Protease Dimerization Interface.|pdf=|usr=}}
{{tp|p=34196550|t=2021. Regulation Mechanism for the Binding between the SARS-CoV-2 Spike Protein and Host Angiotensin-Converting Enzyme II.|pdf=|usr=}}
{{tp|p=34236232|t=2021. Genome Sequences of Two Novel Coronavirus (SARS-CoV-2) Isolates from Dhaka, Bangladesh.|pdf=|usr=}}
{{tp|p=34236224|t=2021. Genome Sequence of a SARS-CoV-2 P.1 Variant of Concern (20J/501Y.V3) from Bangladesh.|pdf=|usr=}}
{{tp|p=34312385|t=2021. Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through 'reverse phenotyping'.|pdf=|usr=}}
{{tp|p=34272374|t=2021. SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance.|pdf=|usr=}}
{{tp|p=34207055|t=2021. microRNA Heterogeneity, Innate-Immune Defense and the Efficacy of SARS-CoV-2 Infection-A Commentary.|pdf=|usr=}}
{{tp|p=34294722|t=2021. Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization.|pdf=|usr=}}
{{tp|p=34232992|t=2021. SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction.|pdf=|usr=}}
{{tp|p=34192263|t=2020. A 3.4-A cryo-electron microscopy structure of the human coronavirus spike trimer computationally derived from vitrified NL63 virus particles.|pdf=|usr=}}
{{tp|p=34290329|t=2021. Kinetics and seroprevalence of SARS-CoV-2 antibodies: a comparison of 3 different assays.|pdf=|usr=}}
{{tp|p=34290262|t=2021. Lipid bilayer degradation induced by SARS-CoV-2 spike protein as revealed by neutron reflectometry.|pdf=|usr=}}
{{tp|p=34215811|t=2021. Early and long term antibody kinetics of asymptomatic and mild disease COVID-19 patients.|pdf=|usr=}}
{{tp|p=34267263|t=2021. A hybrid computational framework for intelligent inter-continent SARS-CoV-2 sub-strains characterization and prediction.|pdf=|usr=}}
{{tp|p=34253751|t=2021. Deep learning identifies antigenic determinants of severe SARS-CoV-2 infection within T-cell repertoires.|pdf=|usr=}}
{{tp|p=34222416|t=2021. Dynamics of host immune responses to SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34370288|t=2021. Emerging Role for Ferroptosis in Infectious Diseases.|pdf=|usr=}}
{{tp|p=34453338|t=2021. In vitro data suggest that Indian delta variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion.|pdf=|usr=}}
{{tp|p=34344757|t=2021. Impaired CD4 T-cell Response to SARS-CoV-2: Rationale for PD-1 Blockade in Patients with Cancer and COVID-19?|pdf=|usr=}}
{{tp|p=34365984|t=2021. Preoperative monocytosis is predictable at diagnosis for RT-PCR negative COVID-19 paediatric cardiac surgery patients.|pdf=|usr=}}
{{tp|p=34348808|t=2021. Cardiac echocardiogram findings of severe acute respiratory syndrome coronavirus-2-associated multi-system inflammatory syndrome in children.|pdf=|usr=}}
{{tp|p=34190246|t=2021. Effective ACE2 peptide-nanoparticle conjugation and its binding with the SARS-Cov-2 RBD quantified by dynamic light scattering.|pdf=|usr=}}
{{tp|p=34218284|t=2021. Long-Term Persistence of Spike Antibody and Predictive Modeling of Antibody Dynamics Following Infection with SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34309648|t=2021. Impact of SARS-CoV-2 variant-associated RBD mutations on the susceptibility to serum antibodies elicited by COVID-19 infection or vaccination.|pdf=|usr=}}
{{tp|p=34302458|t=2021. Neutralizing antibodies against SARS-CoV-2 variants induced by natural infection or vaccination: a systematic review and pooled meta-analysis.|pdf=|usr=}}
{{tp|p=34231319|t=2021. One-year persistence of neutralizing anti-SARS-CoV-2 antibodies in dialysis patients recovered from COVID-19.|pdf=|usr=}}
{{tp|p=34213568|t=2021. Development of IgG, IgM, and IgA autoantibodies against angiotensin converting enzyme 2 in patients with COVID-19.|pdf=|usr=}}
{{tp|p=34188005|t=2021. The interaction of the severe acute respiratory syndrome coronavirus 2 spike protein with drug-inhibited angiotensin converting enzyme 2 studied by molecular dynamics simulation.|pdf=|usr=}}
{{tp|p=34312258|t=2021. The Quality of SARS-CoV-2-Specific T Cell Functions Differs in Patients with Mild/Moderate versus Severe Disease, and T Cells Expressing Coinhibitory Receptors Are Highly Activated.|pdf=|usr=}}
{{tp|p=34301847|t=2021. SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain.|pdf=|usr=}}
{{tp|p=34329672|t=2021. SARS-CoV-2 viral dynamics in infections with Alpha and Beta variants of concern in the French community.|pdf=|usr=}}
{{tp|p=34192326|t=2021. Comment on: Cell Adhesion Molecules and Vascular Endothelial Growth Factor at the Systemic and Alveolar Level in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome.|pdf=|usr=}}
{{tp|p=34192319|t=2021. Cell Adhesion Molecules and Vascular Endothelial Growth Factor at the Systemic and Alveolar Level in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome.|pdf=|usr=}}
{{tp|p=34280026|t=2021. Quantitative Insight into Immunopathology of SARS-CoV-2 Infection.|pdf=|usr=}}
{{tp|p=34251833|t=2021. Integrative Modeling of Plasma Metabolic and Lipoprotein Biomarkers of SARS-CoV-2 Infection in Spanish and Australian COVID-19 Patient Cohorts.|pdf=|usr=}}
{{tp|p=34289271|t=2021. ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant. Reply.|pdf=|usr=}}
{{tp|p=34289270|t=2021. ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant.|pdf=|usr=}}
{{tp|p=34254633|t=2021. Interaction of serum proteins with SARS-CoV-2 RBD.|pdf=|usr=}}
{{tp|p=34316026|t=2021. Broadly neutralizing anti-coronavirus antibodies.|pdf=|usr=}}
{{tp|p=34261126|t=2021. SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.|pdf=|usr=}}
{{tp|p=34237774|t=2021. Mapping the human genetic architecture of COVID-19.|pdf=|usr=}}
{{tp|p=34321649|t=2021. Daily briefing: How SARS-CoV-2 infects cells.|pdf=|usr=}}
{{tp|p=34290423|t=2021. How the Delta variant achieves its ultrafast spread.|pdf=|usr=}}
{{tp|p=34272531|t=2021. Daily briefing: 'Super-antibodies' fight many coronavirus variants.|pdf=|usr=}}
{{tp|p=34262194|t=2021. This 'super antibody' for COVID fights off multiple coronaviruses.|pdf=|usr=}}
{{tp|p=34321669|t=2021. How the coronavirus infects cells - and why Delta is so dangerous.|pdf=|usr=}}
{{tp|p=34239118|t=2021. The quest to find genes that drive severe COVID.|pdf=|usr=}}
{{tp|p=34237773|t=2021. Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization.|pdf=|usr=}}
{{tp|p=34275790|t=2021. Profiling of inflammatory biomarkers in mild to critically ill severe acute respiratory syndrome corona virus-19 (SARS Covid-19) patients from Karachi, Pakistan.|pdf=|usr=}}
{{tp|p=34210785|t=2021. CD8(+) T cells specific for conserved coronavirus epitopes correlate with milder disease in COVID-19 patients.|pdf=|usr=}}
{{tp|p=34233952|t=2021. Increasing threats from SARS-CoV-2 variants: Time to establish global surveillance.|pdf=|usr=}}
{{tp|p=34315827|t=2021. Structural basis of mismatch recognition by a SARS-CoV-2 proofreading enzyme.|pdf=|usr=}}
{{tp|p=34210893|t=2021. SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern.|pdf=|usr=}}
{{tp|p=34301854|t=2021. Spatiotemporal invasion dynamics of SARS-CoV-2 lineage B.1.1.7 emergence.|pdf=|usr=}}
{{tp|p=34210892|t=2021. Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants.|pdf=|usr=}}
{{tp|p=34269109|t=2021. Development of an Image-Based HCS-Compatible Method for Endothelial Barrier Function Assessment.|pdf=|usr=}}

{{tp|p=34284918|t=2021. Imaging of Multisystem Inflammatory Disease in Children (MIS-C) Associated With COVID-19.|pdf=|usr=}}
{{tp|p=34431501|t=2021. COVID-19 and ROS Storm: What is the Forecast for Hypertension.|pdf=|usr=}}
{{tp|p=34273437|t=2021. Outcomes From Infections With Variant Strains of SARS-CoV-2 Among Patients Receiving Maintenance Hemodialysis.|pdf=|usr=}}
{{tp|p=34328495|t=2021. Neutralizing antibody responses against SARS-CoV-2 spike receptor-binding domain 13 months after the recovery from the disease.|pdf=|usr=}}
{{tp|p=34342755|t=2021. Novel phenotypes of coronavirus disease: a temperature-based trajectory model.|pdf=|usr=}}
{{tp|p=34461036|t=2021. Annals Graphic Medicine - Wanted: All COVID-19 Variants.|pdf=|usr=}}
{{tp|p=34374354|t=2022. Prevalence of a Single-Nucleotide Variant of SARS-CoV-2 in Korea and Its Impact on the Diagnostic Sensitivity of the Xpert Xpress SARS-CoV-2 Assay.|pdf=|usr=}}
{{tp|p=34286216|t=2021. Using mixed-effects modeling to estimate decay kinetics of response to SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=34199430|t=2021. Immune Response to SARS-CoV-2 in an Asymptomatic Pediatric Allergic Cohort.|pdf=|usr=}}
{{tp|p=34309328|t=2021. Consenso sobre el tratamiento del sindrome inflamatorio multisistemico asociado a COVID-19.|pdf=|usr=}}
{{tp|p=34419338|t=2021. OBESITY AND SEVERE COVID-19 IN THE YOUNG: IS DOWNREGULATION OF miR-126 A PIECE OF THE SARS-COV2 PATHOGENICITY PUZZLE?|pdf=|usr=}}
{{tp|p=34235495|t=2021. Asymmetric dynamics of dimeric SARS-CoV-2 and SARS-CoV main proteases in an apo form: Molecular dynamics study on fluctuations of active site, catalytic dyad, and hydration water.|pdf=|usr=}}
{{tp|p=34326117|t=2021. Multisystem inflammatory syndrome in an adult following the SARS-CoV-2 vaccine (MIS-V).|pdf=|usr=}}
{{tp|p=34301692|t=2021. Kawasaki-like multisystem inflammatory syndrome associated with SARS-CoV-2 infection in an adult.|pdf=|usr=}}
{{tp|p=34312842|t=2021. Haemophagocytosis and atypical vacuolated lymphocytes in bone marrow and blood films after SARS-CoV-2 vaccination.|pdf=|usr=}}
{{tp|p=34247384|t=2021. Immature platelets in COVID-19 infection.|pdf=|usr=}}
{{tp|p=34230917|t=2021. Impact of SARS-CoV-2 variants on the total CD4(+) and CD8(+) T cell reactivity in infected or vaccinated individuals.|pdf=|usr=}}
{{tp|p=34201214|t=2021. SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2.|pdf=|usr=}}
{{tp|p=34200500|t=2021. How SARS-CoV-2 and Other Viruses Build an Invasion Route to Hijack the Host Nucleocytoplasmic Trafficking System.|pdf=|usr=}}
{{tp|p=34200372|t=2021. ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin.|pdf=|usr=}}
{{tp|p=34201847|t=2021. Cell Death in Coronavirus Infections: Uncovering Its Role during COVID-19.|pdf=|usr=}}
{{tp|p=34202997|t=2021. From RNA World to SARS-CoV-2: The Edited Story of RNA Viral Evolution.|pdf=|usr=}}
{{tp|p=34205262|t=2021. The Role of Th17 Response in COVID-19.|pdf=|usr=}}
{{tp|p=34200572|t=2021. Identification of Lung and Blood Microbiota Implicated in COVID-19 Prognosis.|pdf=|usr=}}
{{tp|p=34272033|t=2021. A dermatologic perspective on multisystem inflammatory syndrome in children.|pdf=|usr=}}
{{tp|p=34272031|t=2021. Dermatologic manifestations of COVID-19-associated multisystem inflammatory syndrome in children.|pdf=|usr=}}
{{tp|p=34303849|t=2021. Understanding the immunological aspects of SARS-CoV-2 causing COVID-19 pandemic: A therapeutic approach.|pdf=|usr=}}
{{tp|p=34245905|t=2021. Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance.|pdf=|usr=}}
{{tp|p=34256141|t=2021. The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses.|pdf=|usr=}}
{{tp|p=34277221|t=2021. A Case of COVID-19 Mimicking Acute Appendicitis in Multi-System Inflammatory Syndrome.|pdf=|usr=}}
{{tp|p=34306899|t=2021. Cardiogenic Shock Due to Multisystem Inflammatory Syndrome in a Young Adult Female.|pdf=|usr=}}
{{tp|p=34314723|t=2021. The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic.|pdf=|usr=}}
{{tp|p=34226898|t=2021. Green bodies: Inclusions in a critically ill COVID-19 patient.|pdf=|usr=}}
{{tp|p=34323691|t=2021. Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains.|pdf=|usr=}}
{{tp|p=34296442|t=2021. SARS-CoV-2 nucleocapsid suppresses host pyroptosis by blocking Gasdermin D cleavage.|pdf=|usr=}}
{{tp|p=34260159|t=2021. Individual COVID-19 disease trajectories revealed by plasma proteomics.|pdf=|usr=}}
{{tp|p=34232570|t=2021. High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion.|pdf=|usr=}}
{{tp|p=34314668|t=2021. Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19.|pdf=|usr=}}
{{tp|p=34296992|t=2021. SARS-CoV-2 Neutralization Resistance Mutations in Patient with HIV/AIDS, California, USA.|pdf=|usr=}}
{{tp|p=34324704|t=2021. SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1.|pdf=|usr=}}
{{tp|p=34318976|t=2021. COVID-19 severity, miR-21 targets, and common human genetic variation. Letter regarding the article 'Circulating cardiovascular microRNAs in critically ill COVID-19 patients'.|pdf=|usr=}}
{{tp|p=34256840|t=2021. The relative expression of miR-31, miR-29, miR-126, and miR-17 and their mRNA targets in the serum of COVID-19 patients with different grades during hospitalization.|pdf=|usr=}}
{{tp|p=34228902|t=2021. Identification of a special cell type as a determinant of the kidney tropism of SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34216102|t=2021. The role of T-cell immunity in COVID-19 severity amongst people living with type II diabetes.|pdf=|usr=}}
{{tp|p=34307198|t=2021. SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro.|pdf=|usr=}}
{{tp|p=34282405|t=2021. Deleterious Effects of SARS-CoV-2 Infection on Human Pancreatic Cells.|pdf=|usr=}}
{{tp|p=34192318|t=2021. Are sialic acids involved in COVID-19 pathogenesis?|pdf=|usr=}}
{{tp|p=34259195|t=2021. A focus on the spread of the delta variant of SARS-CoV-2 in India.|pdf=|usr=}}
{{tp|p=34220204|t=2021. Multisystem Inflammatory Syndrome in Children and Adolescents (MIS-C) under the Setting of COVID-19: A Review of Clinical Presentation, Workup and Management.|pdf=|usr=}}
{{tp|p=34191907|t=2021. Multisystem Inflammatory Syndrome in an Adult With COVID-19.|pdf=|usr=}}
{{tp|p=34213733|t=2021. IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=34324165|t=2021. Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses?|pdf=|usr=}}
{{tp|p=34233864|t=2021. MCP-1: Function, regulation, and involvement in disease.|pdf=|usr=}}
{{tp|p=34284045|t=2021. SARS-CoV-2-infected primary human airway epithelia illustrate mucus hypersecretion.|pdf=|usr=}}
{{tp|p=34224783|t=2021. Mechanisms underlying genetic susceptibility to multisystem inflammatory syndrome in children (MIS-C).|pdf=|usr=}}
{{tp|p=34309742|t=2021. Neutralizing Anti-interferon-gamma Autoantibodies: an Ameliorating Factor in COVID-19 Infection?|pdf=|usr=}}
{{tp|p=34273064|t=2021. Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: a Longitudinal Study.|pdf=|usr=}}
{{tp|p=34196300|t=2021. SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes.|pdf=|usr=}}
{{tp|p=34202613|t=2021. The Role of Neuropilin-1 (NRP-1) in SARS-CoV-2 Infection: Review.|pdf=|usr=}}
{{tp|p=34205655|t=2021. Carboxyhemoglobinemia in Critically Ill Coronavirus Disease 2019 Patients.|pdf=|usr=}}
{{tp|p=34203844|t=2021. SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence.|pdf=|usr=}}
{{tp|p=34188786|t=2021. Extracellular vesicles carry SARS-CoV-2 spike protein and serve as decoys for neutralizing antibodies.|pdf=|usr=}}
{{tp|p=34216637|t=2021. A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV.|pdf=|usr=}}
{{tp|p=34329674|t=2021. Trajectories of hospitalisation for patients infected with SARS-CoV-2 variant B.1.1.7 in Norway, December 2020 - April 2021.|pdf=|usr=}}
{{tp|p=34324939|t=2021. Cross reactivity of serological response to SARS-CoV-2 vaccination with viral variants of concern detected by lateral flow immunoassays.|pdf=|usr=}}
{{tp|p=34320390|t=2021. Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected.|pdf=|usr=}}
{{tp|p=34237342|t=2021. Detection of a SARS-CoV-2 P.1.1 variant lacking N501Y in a vaccinated health care worker in Italy.|pdf=|usr=}}
{{tp|p=34274361|t=2021. Is diffusion of SARS-CoV-2 variants of concern associated with different symptoms?|pdf=|usr=}}
{{tp|p=34241906|t=2021. Genomic characterization of SARS-CoV-2 isolates from patients in Turkey reveals the presence of novel mutations in spike and nsp12 proteins.|pdf=|usr=}}
{{tp|p=34232521|t=2021. N-terminal domain of SARS CoV-2 spike protein mutation associated reduction in effectivity of neutralizing antibody with vaccinated individuals.|pdf=|usr=}}
{{tp|p=34228322|t=2021. Detection of pre-existing SARS-CoV-2-reactive T cells in unexposed renal transplant patients.|pdf=|usr=}}
{{tp|p=34193239|t=2021. COVID-19 (SARS-CoV-2) lymphocyte responses are associated with inflammatory biomarkers in total joint replacement surgery candidates pre-operatively.|pdf=|usr=}}
{{tp|p=34274504|t=2021. Lung Cancer Models Reveal Severe Acute Respiratory Syndrome Coronavirus 2-Induced Epithelial-to-Mesenchymal Transition Contributes to Coronavirus Disease 2019 Pathophysiology.|pdf=|usr=}}
{{tp|p=34283810|t=2021. CD8+PD-L1+CXCR3+ polyfunctional T cell abundances are associated with survival in critical SARS-CoV-2-infected patients.|pdf=|usr=}}
{{tp|p=34291736|t=2021. L-SIGN is a receptor on liver sinusoidal endothelial cells for SARS-CoV-2 virus.|pdf=|usr=}}
{{tp|p=34251356|t=2021. Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay.|pdf=|usr=}}
{{tp|p=34265359|t=2021. Neutralizing antibody response against variants of concern after vaccination of dialysis patients with BNT162b2.|pdf=|usr=}}
{{tp|p=34197809|t=2021. AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC.|pdf=|usr=}}
{{tp|p=34198454|t=2021. Track the dynamical features for mutant variants of COVID-19 in the UK.|pdf=|usr=}}
{{tp|p=34311587|t=2021. B.1.526 SARS-CoV-2 Variants Identified in New York City are Neutralized by Vaccine-Elicited and Therapeutic Monoclonal Antibodies.|pdf=|usr=}}
{{tp|p=34311586|t=2021. D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage.|pdf=|usr=}}
{{tp|p=34311574|t=2021. Murine Monoclonal Antibodies against the Receptor Binding Domain of SARS-CoV-2 Neutralize Authentic Wild-Type SARS-CoV-2 as Well as B.1.1.7 and B.1.351 Viruses and Protect In Vivo in a Mouse Model in a Neutralization-Dependent Manner.|pdf=|usr=}}
{{tp|p=34281387|t=2021. Evolutionary Tracking of SARS-CoV-2 Genetic Variants Highlights an Intricate Balance of Stabilizing and Destabilizing Mutations.|pdf=|usr=}}
{{tp|p=34225491|t=2021. Methyltransferase-like 3 Modulates Severe Acute Respiratory Syndrome Coronavirus-2 RNA N6-Methyladenosine Modification and Replication.|pdf=|usr=}}
{{tp|p=34225487|t=2021. Replicative Fitness of a SARS-CoV-2 20I/501Y.V1 Variant from Lineage B.1.1.7 in Human Reconstituted Bronchial Epithelium.|pdf=|usr=}}
{{tp|p=34291385|t=2021. Computational predictions for protein sequences of COVID-19 virus via machine learning algorithms.|pdf=|usr=}}
{{tp|p=34199617|t=2021. The Emergence of SARS-CoV-2 Variant(s) and Its Impact on the Prevalence of COVID-19 Cases in the Nabatieh Region, Lebanon.|pdf=|usr=}}
{{tp|p=34199203|t=2021. Gut Dysbiosis and IL-21 Response in Patients with Severe COVID-19.|pdf=|usr=}}
{{tp|p=34254825|t=2021. RNA-Protein Interaction Analysis of SARS-CoV-2 5' and 3' Untranslated Regions Reveals a Role of Lysosome-Associated Membrane Protein-2a during Viral Infection.|pdf=|usr=}}
{{tp|p=34221400|t=2021. Differential alterations in peripheral lymphocyte subsets in COVID-19 patients: upregulation of double-positive and double-negative T cells.|pdf=|usr=}}
{{tp|p=34289274|t=2021. Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.|pdf=|usr=}}
{{tp|p=34233096|t=2021. Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.|pdf=|usr=}}
{{tp|p=34218651|t=2021. Review of the early reports of the epidemiological characteristics of the B.1.1.7 variant of SARS-CoV-2 and its spread worldwide.|pdf=|usr=}}
{{tp|p=34270608|t=2021. Infection control, occupational and public health measures including mRNA-based vaccination against SARS-CoV-2 infections to protect healthcare workers from variants of concern: A 14-month observational study using surveillance data.|pdf=|usr=}}
{{tp|p=34270576|t=2021. Is increased mortality by multiple exposures to COVID-19 an overseen factor when aiming for herd immunity?|pdf=|usr=}}
{{tp|p=34242356|t=2021. Immune response dynamics in COVID-19 patients to SARS-CoV-2 and other human coronaviruses.|pdf=|usr=}}
{{tp|p=34279520|t=2021. SARS-CoV-2 Variants in Rhode Island.|pdf=|usr=}}
{{tp|p=34246424|t=2021. Clinical and radiological findings for the new multisystem inflammatory syndrome in children associated with COVID-19.|pdf=|usr=}}
{{tp|p=34231777|t=2021. SARS-CoV-2 nucleic acid shedding is variable for every person.|pdf=|usr=}}
{{tp|p=34273991|t=2021. Estimating COVID-19 cases infected with the variant alpha (VOC 202012/01): an analysis of screening data in Tokyo, January-March 2021.|pdf=|usr=}}
{{tp|p=34211709|t=2021. The emerging SARS-CoV-2 variants of concern.|pdf=|usr=}}
{{tp|p=34405795|t=2021. Inpatient Occupational Therapy Management for a Pediatric Patient With COVID-19 and Multisystem Inflammatory Syndrome in Children: A Case Report.|pdf=|usr=}}
{{tp|p=34212497|t=2021. Humoral response to SARS-CoV-2 is well preserved and symptom dependent in kidney transplant recipients.|pdf=|usr=}}
{{tp|p=34382433|t=2021. Multi-System Inflammatory Syndrome Presenting as Non-Specific Colitis: A Medical Diagnosis with a Surgical Presentation.|pdf=|usr=}}
{{tp|p=34193457|t=2021. How long does covid-19 immunity last?|pdf=|usr=}}
{{tp|p=34254909|t=2021. COVID-19 candidate genes and pathways potentially share the association with lung cancer.|pdf=|usr=}}
{{tp|p=34298578|t=2021. Determination of Factors to Distinguish MIS-C from Acute Appendicitis in Children with Acute Abdominal Pain.|pdf=|usr=}}
{{tp|p=34227076|t=2021. Evolving biothreat of variant SARS-CoV-2 - molecular properties, virulence and epidemiology.|pdf=|usr=}}
{{tp|p=34286505|t=2021. Immunohistochemical findings in the lungs of COVID-19 subjects: evidence of surfactant dysregulation.|pdf=|usr=}}
{{tp|p=34297037|t=2021. Epigenetic and transcriptional control of interferon-beta.|pdf=|usr=}}
{{tp|p=34217595|t=2021. The 'cytokine storm': molecular mechanisms and therapeutic prospects.|pdf=|usr=}}
{{tp|p=34297627|t=2021. Pathogenesis of Coronaviruses Through Human Monocytes and Tissue Macrophages.|pdf=|usr=}}

{{tp|p=34285445|t=2020. COULD COVID-19 BE A HEMOGLOBINOPATHY?|pdf=|usr=}}
{{tp|p=34347313|t=2021. Virus antibodies after SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=34331326|t=2021. Multi-inflammatory syndrome and Kawasaki disease in children during the COVID-19 pandemic: A nationwide register-based study and time series analysis.|pdf=|usr=}}
{{tp|p=34265136|t=2021. SARS-CoV-2 antibodies started to decline just four months after COVID-19 infection in a paediatric population.|pdf=|usr=}}
{{tp|p=34228876|t=2021. Relation between ORF8a and the mitochondrial protein TOM70 in SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=34430865|t=2021. Lymphopenia and IgG2 subclass deficiency in patients with severe COVID-19 pneumonia.|pdf=|usr=}}
{{tp|p=34334284|t=2021. Emergency department levels of NT-proBNP and inotropic/vasoactive support in multi-inflammatory syndrome in children (MIS-C).|pdf=|usr=}}
{{tp|p=34358389|t=2021. Decline in Sars-CoV-2 antibodies over 6-month follow-up in obstetrical healthcare workers.|pdf=|usr=}}
{{tp|p=34407240|t=2021. Molecular mimicry between SARS-CoV-2 and the female reproductive system.|pdf=|usr=}}
{{tp|p=34230709|t=2021. Magnetization Transfer to Enhance NOE Cross-Peaks among Labile Protons: Applications to Imino-Imino Sequential Walks in SARS-CoV-2-Derived RNAs.|pdf=|usr=}}
{{tp|p=34352377|t=2021. Bamlanivimab + etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignancies.|pdf=|usr=}}
{{tp|p=34244164|t=2021. Differentiating multisystem inflammatory syndrome in children: a single-centre retrospective cohort study.|pdf=|usr=}}
{{tp|p=34313714|t=2021. Plasma Levels of Glycohydrolase Activities in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patients.|pdf=|usr=}}
{{tp|p=34219981|t=2021. SARS-CoV-2 Nsp1: Ein kleines Protein blockiert die Immunantwort.|pdf=|usr=}}
{{tp|p=34315173|t=2021. Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets.|pdf=|usr=}}
{{tp|p=34258762|t=2021. Analysis of T-cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in patients with chilblain-like lesions during the COVID-19 pandemic.|pdf=|usr=}}
{{tp|p=34278987|t=2021. Kawasaki disease shock syndrome in the COVID-19 pandemic.|pdf=|usr=}}
{{tp|p=34261560|t=2021. Cardiac implications of multisystem inflammatory syndrome associated with COVID-19 in children under the age of 5 years.|pdf=|usr=}}
{{tp|p=34237283|t=2021. Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects.|pdf=|usr=}}
{{tp|p=34297909|t=2021. Compartmentalization-aided interaction screening reveals extensive high-order complexes within the SARS-CoV-2 proteome.|pdf=|usr=}}
{{tp|p=34250512|t=2021. Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.|pdf=|usr=}}
{{tp|p=34293929|t=2021. SARS-CoV-2 Initiates Programmed Cell Death in Platelets.|pdf=|usr=}}
{{tp|p=34238021|t=2021. Disrupted Resolution Mechanisms Favor Altered Phagocyte Responses in COVID-19.|pdf=|usr=}}
{{tp|p=34208057|t=2021. Case Series of Multisystem Inflammatory Syndrome (MIS-C) in Children during the SARS-CoV-2 Pandemic in Latvia.|pdf=|usr=}}
{{tp|p=34257967|t=2021. SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.|pdf=|usr=}}
{{tp|p=34281966|t=2021. Achieving and sustaining herd immunity to SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34253551|t=2021. Alpha, Beta, Delta, Gamma: What's important to know about SARS-CoV-2 variants of concern?|pdf=|usr=}}
{{tp|p=34250324|t=2021. Silent hypoxia in COVID-19: a gut microbiota connection.|pdf=|usr=}}
{{tp|p=34264880|t=2021. Is severe COVID-19 a cytokine storm syndrome: a hyperinflammatory debate.|pdf=|usr=}}
{{tp|p=34189489|t=2021. SARS-CoV-2 NSP1 C-terminal (residues 131-180) is an intrinsically disordered region in isolation.|pdf=|usr=}}
{{tp|p=34216296|t=2021. Current Understanding of Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 and Its Distinction from Kawasaki Disease.|pdf=|usr=}}
{{tp|p=34242899|t=2021. Between immunomodulation and immunotolerance: The role of IFNgamma in SARS-CoV-2 disease.|pdf=|usr=}}
{{tp|p=34441178|t=2021. Entropy and Fractal Dimension Study of the TDP-43 Protein Low Complexity Domain Sequence in ALS Disease Severity and SARS-CoV-2 Gene Sequences in Virulence Variability.|pdf=|usr=}}
{{tp|p=34383213|t=2021. Deciphering epigenetic(s) role in modulating susceptibility to and severity of COVID-19 infection and/or outcome: a systematic rapid review.|pdf=|usr=}}
{{tp|p=34375814|t=2021. Modeling the population effects of escape mutations in SARS-CoV-2 to guide vaccination strategies.|pdf=|usr=}}
{{tp|p=34412446|t=2021. Herd immunity: challenges and the way forward in Korea.|pdf=|usr=}}
{{tp|p=34255566|t=2021. Secretory phospholipase A2 in SARS-CoV-2 infection and multisystem inflammatory syndrome in children (MIS-C).|pdf=|usr=}}
{{tp|p=34253862|t=2021. Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms.|pdf=|usr=}}
{{tp|p=34324734|t=2021. Dimethyl sulfoxide reduces the stability but enhances catalytic activity of the main SARS-CoV-2 protease 3CLpro.|pdf=|usr=}}
{{tp|p=34222140|t=2021. Similarities and Differences Between COVID-19-Related Multisystem Inflammatory Syndrome in Children and Kawasaki Disease.|pdf=|usr=}}
{{tp|p=34194534|t=2021. V483A: an emerging mutation hotspot of SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34219999|t=2021. Notable and Emerging Variants of SARS-CoV-2 Virus: A Quick Glance.|pdf=|usr=}}
{{tp|p=34269987|t=2021. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19 Infection.|pdf=|usr=}}
{{tp|p=34286362|t=2021. SARS-CoV-2 and pathological matrix remodeling mediators.|pdf=|usr=}}
{{tp|p=34241783|t=2021. SARS-CoV-2 may trigger inflammasome and pyroptosis in the central nervous system: a mechanistic view of neurotropism.|pdf=|usr=}}
{{tp|p=34264010|t=2021. Determinants of having severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in Egypt.|pdf=|usr=}}
{{tp|p=34307830|t=2021. In-Silico analysis reveals lower transcription efficiency of C241T variant of SARS-CoV-2 with host replication factors MADP1 and hnRNP-1.|pdf=|usr=}}
{{tp|p=34289645|t=2021. Letter to editor: Alimentary system is directly attacked by SARS-COV-2 and further prevents immune dysregulation caused by COVID-19.|pdf=|usr=}}
{{tp|p=34195921|t=2021. High anti-SARS-CoV-2 antibody seroprevalence in healthcare workers in an Irish university teaching hospital.|pdf=|usr=}}
{{tp|p=34237902|t=2021. Noneffect of SARS-CoV-2 spike glycoprotein Y217N mutation on affinity between the virus and ACE2.|pdf=|usr=}}
{{tp|p=34237894|t=2021. Reply to Hayashi and Konishi: Noneffect of SARS-CoV-2 spike glycoprotein Y217N mutation on affinity between virus and ACE2.|pdf=|usr=}}
{{tp|p=34237302|t=2021. Recombinant SARS-CoV-2 envelope protein traffics to the trans-Golgi network following amphipol-mediated delivery into human cells.|pdf=|usr=}}
{{tp|p=34270181|t=2021. What is Currently Known About the SARS-CoV2 Variants of Concern.|pdf=|usr=}}
{{tp|p=34238684|t=2021. Progressive deterioration of the upper respiratory tract and the gut microbiomes in children during the early infection stages of COVID-19.|pdf=|usr=}}
{{tp|p=34252180|t=2021. Surviving older patients show preserved cellular and humoral immunological memory several months after SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=34273592|t=2021. Loss-of-function mutations in IFNAR2 in COVID-19 severe infection susceptibility.|pdf=|usr=}}
{{tp|p=34327751|t=2021. Cardiac Magnetic Resonance Follow-Up of Children After Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 With Initial Cardiac Involvement.|pdf=|usr=}}
{{tp|p=34288064|t=2021. A role for T-cell exhaustion in Long COVID-19 and severe outcomes for several categories of COVID-19 patients.|pdf=|usr=}}
{{tp|p=34248441|t=2021. Multisystem Inflammatory Syndrome in Children.|pdf=|usr=}}
{{tp|p=34203982|t=2021. Severe COVID-19 in Hospitalized Carriers of Single CFTR Pathogenic Variants.|pdf=|usr=}}
{{tp|p=34225749|t=2021. HLA-dependent heterogeneity and macrophage immunoproteasome activation during lung COVID-19 disease.|pdf=|usr=}}
{{tp|p=34260266|t=2021. SARS-CoV-2 Disrupts Proximal Elements in the JAK-STAT Pathway.|pdf=|usr=}}
{{tp|p=34228642|t=2021. Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents.|pdf=|usr=}}
{{tp|p=34265238|t=2021. Lifting of COVID-19 restrictions in the UK and the Delta variant.|pdf=|usr=}}
{{tp|p=34204549|t=2021. The Role of Coronavirus RNA-Processing Enzymes in Innate Immune Evasion.|pdf=|usr=}}
{{tp|p=34239770|t=2021. Multisystem Inflammatory Syndrome in Adults (MIS-A) Associated with SARS-CoV-2 Infection in a Young Adult Case from Turkey.|pdf=|usr=}}
{{tp|p=34208136|t=2021. NOX2 Activation in COVID-19: Possible Implications for Neurodegenerative Diseases.|pdf=|usr=}}
{{tp|p=34264910|t=2021. SARS-CoV-2 B.1.617.2 (Delta) Variant COVID-19 Outbreak Associated with a Gymnastics Facility - Oklahoma, April-May 2021.|pdf=|usr=}}
{{tp|p=34280038|t=2021. Traces of SARS-CoV-2 RNA in Peripheral Blood Cells of Patients with COVID-19.|pdf=|usr=}}
{{tp|p=34322566|t=2021. Systemic Inflammation and Microbial Translocation Are Characteristic Features of SARS-CoV-2-Related Multisystem Inflammatory Syndrome in Children.|pdf=|usr=}}
{{tp|p=34322559|t=2021. CD8+ T-Cell Responses in COVID-19 Convalescent Individuals Target Conserved Epitopes From Multiple Prominent SARS-CoV-2 Circulating Variants.|pdf=|usr=}}
{{tp|p=34295945|t=2021. Time Course of Neutralizing Antibody in Health Care Workers With Mild or Asymptomatic COVID-19 Infection.|pdf=|usr=}}
{{tp|p=34295944|t=2021. SARS-CoV-2 Subgenomic RNA Kinetics in Longitudinal Clinical Samples.|pdf=|usr=}}
{{tp|p=34306718|t=2021. Orchiepididymitis in the context of multisystem inflammatory syndrome in a child with Covid-19 from Syria: a very rare presentation for SARS-Cov-19 in children.|pdf=|usr=}}
{{tp|p=34192268|t=2020. Innate immunology in COVID-19-a living review. Part II: dysregulated inflammation drives immunopathology.|pdf=|usr=}}
{{tp|p=34192267|t=2020. Innate immunology in COVID-19-a living review. Part I: viral entry, sensing and evasion.|pdf=|usr=}}
{{tp|p=34187503|t=2021. Intravenous administration of anakinra in children with macrophage activation syndrome.|pdf=|usr=}}
{{tp|p=34315200|t=2021. Interplays between human microbiota and microRNAs in COVID-19 pathogenesis: a literature review.|pdf=|usr=}}
{{tp|p=34228753|t=2021. Characterization of low-density granulocytes in COVID-19.|pdf=|usr=}}
{{tp|p=34292871|t=2021. Ongoing global and regional adaptive evolution of SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34231823|t=2021. Early detection of SARS-CoV-2 P.1 variant in Southern Brazil and reinfection of the same patient by P.2.|pdf=|usr=}}
{{tp|p=34191369|t=2021. Persistence of humoral response upon SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=34260780|t=2021. A systematic meta-analysis of immune signatures in patients with COVID-19.|pdf=|usr=}}
{{tp|p=34305429|t=2021. Relevance between COVID-19 and host genetics of immune response.|pdf=|usr=}}
{{tp|p=34234112|t=2021. The signal pathways and treatment of cytokine storm in COVID-19.|pdf=|usr=}}
{{tp|p=34234102|t=2021. SARS-CoV-2-specific immune response in COVID-19 convalescent individuals.|pdf=|usr=}}
{{tp|p=34315848|t=2021. Assessment of infectivity and the impact on neutralizing activity of immune sera of the COVID-19 variant, CAL.20C.|pdf=|usr=}}
{{tp|p=34315847|t=2021. N501Y mutation imparts cross-species transmission of SARS-CoV-2 to mice by enhancing receptor binding.|pdf=|usr=}}
{{tp|p=34253708|t=2021. The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction.|pdf=|usr=}}
{{tp|p=34315677|t=2021. Dynamics of anti-SARS-CoV-2 antibodies in repeat convalescent plasma donors.|pdf=|usr=}}
{{tp|p=34230895|t=2021. Preexisting vs. de novo antibodies against SARS-CoV-2 in individuals without or with virus infection: impact on antibody therapy, vaccine research and serological testing.|pdf=|usr=}}
{{tp|p=34274029|t=2021. Reverse Transcription Polymerase Chain Reaction Pattern of SARS-CoV-2 Beta Variant.|pdf=|usr=}}
{{tp|p=34383706|t=2021. Alpha variant (B.1.1.7) of SARS-CoV-2 increases fatality-rate for patients under age of 70 years and hospitalization risk overall.|pdf=|usr=}}
{{tp|p=34432905|t=2021. Incidence rate of MIS-C in paediatrics: A good reason to vaccinate children against SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34279831|t=2021. Intestinal Microbiota in the SARS-CoV-2 Infection: What Is Known?|pdf=|usr=}}
{{tp|p=34418362|t=2021. The NHLBI Study on Long-terM OUtcomes after the Multisystem Inflammatory Syndrome In Children (MUSIC): Design and Objectives.|pdf=|usr=}}
{{tp|p=34413034|t=2021. Sudden cardiac death in a young boy with multisystemic inflammatory syndrome in children (MISC).|pdf=|usr=}}
{{tp|p=34213849|t=2021. Structure-function relations of the SARS-CoV-2 spike protein and impact of mutations in the variants of concern.|pdf=|usr=}}
{{tp|p=34213846|t=2021. Insufficient type I IFN immunity underlies life-threatening COVID-19 pneumonia.|pdf=|usr=}}
{{tp|p=34213845|t=2021. COVID-19: individual and herd immunity.|pdf=|usr=}}
{{tp|p=34265244|t=2021. The devil in the details: Herd immunity and pandemic response.|pdf=|usr=}}
{{tp|p=34251316|t=2021. SARS-CoV-2 infection may not be a prerequisite for developing multisystem inflammatory syndrome in children.|pdf=|usr=}}
{{tp|p=34259663|t=2021. Coronavirus Disease 2019 as Cause of Viral Sepsis: A Systematic Review and Meta-Analysis.|pdf=|usr=}}
{{tp|p=34269657|t=2021. The role of PCSK9 in infectious diseases.|pdf=|usr=}}
{{tp|p=34189878|t=2021. COVID 19 in India: Waves, Variants of Concern, Airborne Transmission.|pdf=|usr=}}
{{tp|p=34233453|t=2021. Viral shedding in symptomatic patients with mild COVID-19: an experience with nebulized nasal treatment.|pdf=|usr=}}
{{tp|p=34229570|t=2021. Comparative analysis of SARS-CoV-2 envelope viroporin mutations from COVID-19 deceased and surviving patients revealed implications on its ion-channel activities and correlation with patient mortality.|pdf=|usr=}}
{{tp|p=34323931|t=2021. Presumed SARS-CoV-2 Viral Particles in the Human Retina of Patients With COVID-19.|pdf=|usr=}}
{{tp|p=34287999|t=2021. Structural insights into the distinctive RNA recognition and therapeutic potentials of RIG-I-like receptors.|pdf=|usr=}}
{{tp|p=34266903|t=2021. Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children.|pdf=|usr=}}
{{tp|p=34225390|t=2021. Triangle of cytokine storm, central nervous system involvement, and viral infection in COVID-19: the role of sFasL and neuropilin-1.|pdf=|usr=}}
{{tp|p=34190914|t=2021. Sindrome inflamatorio multisistemico pediatrico asociado a COVID-19: reporte preliminar de un hospital del Peru.|pdf=|usr=}}

{{tp|p=34425281|t=2021. Mutation-induced changes in the receptor-binding interface of the SARS-CoV-2 Delta variant B.1.617.2 and implications for immune evasion.|pdf=|usr=}}
{{tp|p=34336288|t=2021. Coronavirus Disease 2019-Related Multisystem Inflammatory Syndrome in Children: A Systematic Review and Meta-Analysis.|pdf=|usr=}}
{{tp|p=34351418|t=2021. Host ADP-ribosylation and the SARS-CoV-2 macrodomain.|pdf=|usr=}}
{{tp|p=34461258|t=2021. SARS-CoV-2 spike promotes inflammation and apoptosis through autophagy by ROS-suppressed PI3K/AKT/mTOR signaling.|pdf=|usr=}}
{{tp|p=34364043|t=2021. Interleukin-17A (IL-17A): A silent amplifier of COVID-19.|pdf=|usr=}}
{{tp|p=34356872|t=2021. Different Within-Host Viral Evolution Dynamics in Severely Immunosuppressed Cases with Persistent SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34440241|t=2021. Structural Dissection of Viral Spike-Protein Binding of SARS-CoV-2 and SARS-CoV-1 to the Human Angiotensin-Converting Enzyme 2 (ACE2) as Cellular Receptor.|pdf=|usr=}}
{{tp|p=34453696|t=2021. (1)H, (13)C and (15)N assignment of stem-loop SL1 from the 5'-UTR of SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34439792|t=2021. Relevance of BET Family Proteins in SARS-CoV-2 Infection.|pdf=|usr=}}
{{tp|p=34439910|t=2021. Molecular Dynamics Simulation Study of the Interaction between Human Angiotensin Converting Enzyme 2 and Spike Protein Receptor Binding Domain of the SARS-CoV-2 B.1.617 Variant.|pdf=|usr=}}
{{tp|p=34439887|t=2021. HMGB1-TIM3-HO1: A New Pathway of Inflammation in Skin of SARS-CoV-2 Patients? A Retrospective Pilot Study.|pdf=|usr=}}
{{tp|p=34439868|t=2021. Cytokine Storms in the Course of COVID-19 and Haemophagocytic Lymphohistiocytosis in Pregnant and Postpartum Women.|pdf=|usr=}}
{{tp|p=34349042|t=2021. Green-blue intracytoplasmic inclusions in the bone marrow in severe COVID-19.|pdf=|usr=}}
{{tp|p=34388982|t=2021. Hemophagocytic syndrome secondary to SARS-Cov-2 infection: a case report.|pdf=|usr=}}
{{tp|p=34373240|t=2021. Severe acute inflammatory myositis and rhabdomyolysis in paediatric SARS-CoV-2-associated MIS-C (multisystem inflammatory syndrome in children).|pdf=|usr=}}
{{tp|p=34380685|t=2021. Transient acetylcholine receptor-related myasthenia gravis, post multisystem inflammatory syndrome in children (MIS-C) temporally associated with COVID-19 infection.|pdf=|usr=}}
{{tp|p=34351888|t=2021. Lactante criticamente enfermo con sindrome inflamatorio multisistemico relacionado con COVID-19.|pdf=|usr=}}
{{tp|p=34392826|t=2021. Sustained seroprevalence of SARS-CoV-2 antibodies one year after infection: one of the first COVID-19 cluster cases in Bosnia and Herzegovina.|pdf=|usr=}}
{{tp|p=34428473|t=2021. The impact of spike mutated variants of SARS-CoV2 [Alpha, Beta, Gamma, Delta, and Lambda] on the efficacy of subunit recombinant vaccines.|pdf=|usr=}}
{{tp|p=34382087|t=2021. Data-driven identification of SARS-CoV-2 subpopulations using PhenoGraph and binary-coded genomic data.|pdf=|usr=}}
{{tp|p=34421386|t=2021. Epidemiologic and clinical characteristics of multisystem inflammatory syndrome in adults: a rapid review.|pdf=|usr=}}
{{tp|p=34385216|t=2021. Le syndrome inflammatoire multisystemique post-COVID-19 chez les enfants.|pdf=|usr=}}
{{tp|p=34385205|t=2021. Post-COVID-19 multisystem inflammatory syndrome in children.|pdf=|usr=}}
{{tp|p=34367385|t=2021. The Relationship between Pre-Pandemic Interferon Gamma Release Assay Test Results and COVID-19 Infection: Potential Prognostic Value of Indeterminate IFN-gamma Release Assay Results.|pdf=|usr=}}
{{tp|p=34386717|t=2021. Salivary markers and coronavirus disease 2019: insights from cross-talk between the oral microbiome and pulmonary and systemic low-grade inflammation and implications for vascular complications.|pdf=|usr=}}
{{tp|p=34352228|t=2021. Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19.|pdf=|usr=}}
{{tp|p=34332650|t=2021. Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike.|pdf=|usr=}}
{{tp|p=34351662|t=2021. Role of hemagglutinin-esterase protein in SARS-CoV-2 infection?|pdf=|usr=}}
{{tp|p=34389814|t=2021. SARS-CoV-2 N501Y variants of concern and their potential transmission by mouse.|pdf=|usr=}}
{{tp|p=34385425|t=2021. Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2-host interactome.|pdf=|usr=}}
{{tp|p=34429403|t=2021. Pyroptosis of syncytia formed by fusion of SARS-CoV-2 spike and ACE2-expressing cells.|pdf=|usr=}}
{{tp|p=34400613|t=2021. Molecular determinants for regulation of G3BP1/2 phase separation by the SARS-CoV-2 nucleocapsid protein.|pdf=|usr=}}
{{tp|p=34426672|t=2021. Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination.|pdf=|usr=}}
{{tp|p=34413488|t=2021. Activation or exhaustion of CD8(+) T cells in patients with COVID-19.|pdf=|usr=}}
{{tp|p=34433083|t=2021. The nucleotide addition cycle of the SARS-CoV-2 polymerase.|pdf=|usr=}}
{{tp|p=34416153|t=2021. One-shot identification of SARS-CoV-2 S RBD escape mutants using yeast screening.|pdf=|usr=}}
{{tp|p=34380018|t=2021. No evidence of human genome integration of SARS-CoV-2 found by long-read DNA sequencing.|pdf=|usr=}}
{{tp|p=34358460|t=2021. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms.|pdf=|usr=}}
{{tp|p=34341488|t=2021. O-glycosylation pattern of the SARS-CoV-2 spike protein reveals an "O-Follow-N" rule.|pdf=|usr=}}
{{tp|p=34438017|t=2021. A novel hypothesis for COVID-19 pathogenesis: Retinol depletion and retinoid signaling disorder.|pdf=|usr=}}
{{tp|p=34359986|t=2021. Role of Multifunctional Cytoskeletal Filaments in Coronaviridae Infections: Therapeutic Opportunities for COVID-19 in a Nutshell.|pdf=|usr=}}
{{tp|p=34359983|t=2021. SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling.|pdf=|usr=}}
{{tp|p=34359957|t=2021. MiRNA Profiling in Plasma and Placenta of SARS-CoV-2-Infected Pregnant Women.|pdf=|usr=}}
{{tp|p=34359932|t=2021. Viral MicroRNAs Encoded by Nucleocapsid Gene of SARS-CoV-2 Are Detected during Infection, and Targeting Metabolic Pathways in Host Cells.|pdf=|usr=}}
{{tp|p=34359931|t=2021. Cytokine Storm Syndrome in SARS-CoV-2 Infections: A Functional Role of Mast Cells.|pdf=|usr=}}
{{tp|p=34440791|t=2021. The Molecular Interplay between Human Coronaviruses and Autophagy.|pdf=|usr=}}
{{tp|p=34440767|t=2021. Microbiota-Gut-Brain Communication in the SARS-CoV-2 Infection.|pdf=|usr=}}
{{tp|p=34440765|t=2021. Autophagy and Mitophagy-Related Pathways at the Crossroads of Genetic Pathways Involved in Familial Sarcoidosis and Host-Pathogen Interactions Induced by Coronaviruses.|pdf=|usr=}}
{{tp|p=34440903|t=2021. Implications of Innate Immunity in Post-Acute Sequelae of Non-Persistent Viral Infections.|pdf=|usr=}}
{{tp|p=34440879|t=2021. Expansion of Myeloid Derived Suppressor Cells Contributes to Platelet Activation by L-Arginine Deprivation during SARS-CoV-2 Infection.|pdf=|usr=}}
{{tp|p=34440816|t=2021. Secretory Vesicles Are the Principal Means of SARS-CoV-2 Egress.|pdf=|usr=}}
{{tp|p=34356552|t=2021. Neonatal Multisystem Inflammatory Syndrome (MIS-N) Associated with Prenatal Maternal SARS-CoV-2: A Case Series.|pdf=|usr=}}
{{tp|p=34438603|t=2021. MIS-C-Implications for the Pediatric Surgeon: An Algorithm for Differential Diagnostic Considerations.|pdf=|usr=}}
{{tp|p=34353002|t=2021. Clinical spectrum and short-term outcomes of multisystem inflammatory syndrome in children in a south Indian hospital.|pdf=|usr=}}
{{tp|p=34343708|t=2021. Longitudinal observation of antibody responses for 14 months after SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=34458720|t=2021. Multisystem inflammatory syndrome in adults following COVID-19 infection: A case report presenting with colitis.|pdf=|usr=}}
{{tp|p=34391929|t=2021. Mucosal immunity to SARS-CoV-2: a clinically relevant key to deciphering natural and vaccine-induced defences.|pdf=|usr=}}
{{tp|p=34455390|t=2021. Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection.|pdf=|usr=}}
{{tp|p=34419923|t=2021. Neutralisation titres against SARS-CoV-2 are sustained 6 months after onset of symptoms in individuals with mild COVID-19.|pdf=|usr=}}
{{tp|p=34392145|t=2021. High throughput diagnostics and dynamic risk assessment of SARS-CoV-2 variants of concern.|pdf=|usr=}}
{{tp|p=34401689|t=2021. Changing composition of SARS-CoV-2 lineages and rise of Delta variant in England.|pdf=|usr=}}
{{tp|p=34350827|t=2021. Unsupervised machine learning reveals key immune cell subsets in COVID-19, rhinovirus infection, and cancer therapy.|pdf=|usr=}}
{{tp|p=34435953|t=2021. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.|pdf=|usr=}}
{{tp|p=34424199|t=2021. Integrated single-cell analysis unveils diverging immune features of COVID-19, influenza, and other community-acquired pneumonia.|pdf=|usr=}}
{{tp|p=34414888|t=2021. SARS-CoV-2 shedding dynamics across the respiratory tract, sex, and disease severity for adult and pediatric COVID-19.|pdf=|usr=}}
{{tp|p=34414884|t=2021. N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2.|pdf=|usr=}}
{{tp|p=34402426|t=2021. A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance.|pdf=|usr=}}
{{tp|p=34387545|t=2021. Patterns of within-host genetic diversity in SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34375000|t=2021. Identification of lectin receptors for conserved SARS-CoV-2 glycosylation sites.|pdf=|usr=}}
{{tp|p=34352197|t=2021. SARS-CoV-2 Variants in Immunocompromised Patient Given Antibody Monotherapy.|pdf=|usr=}}
{{tp|p=34437831|t=2021. Real-Time Genomic Surveillance for SARS-CoV-2 Variants of Concern, Uruguay.|pdf=|usr=}}
{{tp|p=34388358|t=2021. Rapid Increase in SARS-CoV-2 P.1 Lineage Leading to Codominance with B.1.1.7 Lineage, British Columbia, Canada, January-April 2021.|pdf=|usr=}}
{{tp|p=34402744|t=2021. Host-dependent editing of SARS-CoV-2 in COVID-19 patients.|pdf=|usr=}}
{{tp|p=34396940|t=2021. Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case-control real-world study.|pdf=|usr=}}
{{tp|p=34400021|t=2021. Aparicion de novo de la mutacion E484K en una variante del linaje B.1.1.7 de SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34365657|t=2021. Spike protein of SARS-CoV-2 activates macrophages and contributes to induction of acute lung inflammation in male mice.|pdf=|usr=}}
{{tp|p=34339064|t=2021. S100A8 may govern hyper-inflammation in severe COVID-19.|pdf=|usr=}}
{{tp|p=34398806|t=2021. Specific COVID-19 Symptoms Correlate with High Antibody Levels against SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34355822|t=2021. Walking down the memory lane with SARS-CoV-2 B cells.|pdf=|usr=}}
{{tp|p=34382228|t=2021. Sensitive detection of anti-spike antibodies enables improved understanding of SARS-CoV-2 pathogenesis.|pdf=|usr=}}
{{tp|p=34446125|t=2021. Early detection of the SARS-CoV-2 P.1 variant in Rio Grande do Sul, Brazil: a case report.|pdf=|usr=}}
{{tp|p=34414454|t=2021. MicroRNA283p inhibits angiotensinconverting enzyme 2 ectodomain shedding in 293T cells treated with the spike protein of severe acute respiratory syndrome coronavirus 2 by targeting A disintegrin and metalloproteinase 17.|pdf=|usr=}}
{{tp|p=34346720|t=2021. Elevated Rates of Indeterminate Results on QuantiFERON-TB Gold Plus in COVID-19 Patients.|pdf=|usr=}}
{{tp|p=34379531|t=2021. Acquisition of the L452R Mutation in the ACE2-Binding Interface of Spike Protein Triggers Recent Massive Expansion of SARS-CoV-2 Variants.|pdf=|usr=}}
{{tp|p=34379530|t=2021. The Fall in Antibody Response to SARS-CoV-2: a Longitudinal Study of Asymptomatic to Critically Ill Patients Up to 10 Months after Recovery.|pdf=|usr=}}
{{tp|p=34428777|t=2021. Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York.|pdf=|usr=}}
{{tp|p=34332518|t=2021. Could metabolomics drive the fate of COVID-19 pandemic? A narrative review on lights and shadows.|pdf=|usr=}}
{{tp|p=34414796|t=2021. Henoch-Schonlein Purpura in a COVID-19-Positive Child With Abdominal Pain and PIMS-TS.|pdf=|usr=}}
{{tp|p=34417262|t=2021. LTB4-Driven Inflammation and Increased Expression of ALOX5/ACE2 During Severe COVID-19 in Individuals With Diabetes.|pdf=|usr=}}
{{tp|p=34424997|t=2021. SARS-CoV-2-reactive T-cell receptors isolated from convalescent COVID-19 patients confer potent T-cell effector function.|pdf=|usr=}}
{{tp|p=34355378|t=2021. Alterations in lymphocyte subsets and monocytes in patients diagnosed with SARS-CoV-2 pneumonia: a mini review of the literature.|pdf=|usr=}}
{{tp|p=34341181|t=2021. Hemodialysis Patients Make Long-Lived Antibodies against SARS-CoV-2 that May Be Associated with Reduced Reinfection.|pdf=|usr=}}
{{tp|p=34338591|t=2021. Evolving ribonucleocapsid assembly/packaging signals in the genomes of the human and animal coronaviruses: targeting, transmission and evolution.|pdf=|usr=}}
{{tp|p=34371513|t=2021. Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 Infection and Escherichia coli Sepsis: The Role of Procalcitonin for Differential Diagnosis.|pdf=|usr=}}
{{tp|p=34346865|t=2021. Memoire immunitaire contre le SARS-CoV-2 - Des anticorps contre l'infection initiale et des lymphocytes B a memoire contre les infections futures.|pdf=|usr=}}
{{tp|p=34346864|t=2021. Par ici la sortie ! Le SARS-CoV-2 utilise les lysosomes pour sortir de la cellule infectee.|pdf=|usr=}}
{{tp|p=34347959|t=2021. SARS-CoV-2 Variants in Patients with Immunosuppression.|pdf=|usr=}}
{{tp|p=34407350|t=2021. Audio Interview: Aspects of Covid-19 Immunity.|pdf=|usr=}}
{{tp|p=34376850|t=2021. The lag in SARS-CoV-2 genome submissions to GISAID.|pdf=|usr=}}
{{tp|p=34408314|t=2021. Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children.|pdf=|usr=}}
{{tp|p=34413500|t=2021. A glycan gate controls opening of the SARS-CoV-2 spike protein.|pdf=|usr=}}
{{tp|p=34363044|t=2021. Coronavirus footprints.|pdf=|usr=}}
{{tp|p=34426697|t=2021. Cryo-EM and antisense targeting of the 28-kDa frameshift stimulation element from the SARS-CoV-2 RNA genome.|pdf=|usr=}}
{{tp|p=34385690|t=2021. Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function.|pdf=|usr=}}
{{tp|p=34373640|t=2021. Remember Beta? New data reveal variant's deadly powers.|pdf=|usr=}}
{{tp|p=34413530|t=2021. Delta's rise is fuelled by rampant spread from people who feel fine.|pdf=|usr=}}
{{tp|p=34413527|t=2021. COVID vaccines protect against Delta, but their effectiveness wanes.|pdf=|usr=}}
{{tp|p=34417582|t=2021. The mutation that helps Delta spread like wildfire.|pdf=|usr=}}
{{tp|p=34385613|t=2021. How do vaccinated people spread Delta? What the science says.|pdf=|usr=}}
{{tp|p=34354278|t=2021. Delta threatens rural regions that dodged earlier COVID waves.|pdf=|usr=}}
{{tp|p=34363057|t=2020. Daily briefing: The wildly complicated immune response to COVID-19.|pdf=|usr=}}
{{tp|p=34346604|t=2021. Covid-19-geassocieerde 'multisystem inflammatory syndrome'.|pdf=|usr=}}

{{tp|p=34423834|t=2021. Clinical and virological features of SARS-CoV-2 variants of concern: a retrospective cohort study comparing B.1.1.7 (Alpha), B.1.315 (Beta), and B.1.617.2 (Delta).|pdf=|usr=}}
{{tp|p=34389636|t=2021. Secondary haemophagocytic lymphohistiocytosis in hospitalised COVID-19 patients as indicated by a modified HScore is infrequent and high scores do not associate with increased mortality.|pdf=|usr=}}
{{tp|p=34384361|t=2021. Mass spectrometry-based proteomics in basic and translational research of SARS-CoV-2 coronavirus and its emerging mutants.|pdf=|usr=}}
{{tp|p=34391590|t=2021. Conversations With the Editors: The Emergence of Variants Amid Population-Wide SARS-CoV-2 Vaccination Efforts: How Much Should We Worry?|pdf=|usr=}}
{{tp|p=34429968|t=2021. Antibodies against type I interferon: detection and association with severe clinical outcome in COVID-19 patients.|pdf=|usr=}}
{{tp|p=34336207|t=2021. Decline in neutralising antibody responses, but sustained T-cell immunity, in COVID-19 patients at 7 months post-infection.|pdf=|usr=}}
{{tp|p=34345007|t=2021. Identification, mapping and relative quantitation of SARS-CoV-2 Spike glycopeptides by Mass-Retention Time Fingerprinting.|pdf=|usr=}}
{{tp|p=34429502|t=2021. The structure of a dimeric form of SARS-CoV-2 polymerase.|pdf=|usr=}}
{{tp|p=34346317|t=2021. Investigation of nonsynonymous mutations in the spike protein of SARS-CoV-2 and its interaction with the ACE2 receptor by molecular docking and MM/GBSA approach.|pdf=|usr=}}
{{tp|p=34336146|t=2021. Binding affinity and mechanisms of SARS-CoV-2 variants.|pdf=|usr=}}
{{tp|p=34336145|t=2021. Immune evasion of SARS-CoV-2 from interferon antiviral system.|pdf=|usr=}}
{{tp|p=34395179|t=2021. SARS-CoV spike proteins can compete for electrolytes in physiological fluids according to structure-based quantum-chemical calculations.|pdf=|usr=}}
{{tp|p=34336449|t=2021. Roles and Interplay of SARS-CoV-2 Serology With Clinical Stages of Disease in COVID-19.|pdf=|usr=}}
{{tp|p=34336414|t=2021. Acute Appendicitis Associated With Multisystem Inflammatory Syndrome in Children.|pdf=|usr=}}
{{tp|p=34422477|t=2021. Case Series of Clinical Findings of Multi-System Inflammatory Syndrome in Children in Contrast to Kawasaki Disease.|pdf=|usr=}}
{{tp|p=34454352|t=2021. Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?|pdf=|usr=}}
{{tp|p=34383898|t=2021. Comparison of cardiac computed tomography findings of Kawasaki disease and post-COVID-19 coronary aneurysms.|pdf=|usr=}}
{{tp|p=34333764|t=2021. Maturation signatures of conventional dendritic cell subtypes in COVID-19 suggest direct viral sensing.|pdf=|usr=}}
{{tp|p=34425479|t=2021. Acute encephalitis in pediatric multisystem inflammatory syndrome associated with COVID-19.|pdf=|usr=}}
{{tp|p=34447577|t=2021. Variants in SARS-CoV-2 associated with mild or severe outcome.|pdf=|usr=}}
{{tp|p=34453107|t=2021. Mutational spectrum of SARS-CoV-2 during the global pandemic.|pdf=|usr=}}
{{tp|p=34409597|t=2021. Interface-based design of the favipiravir-binding site in SARS-CoV-2 RNA-dependent RNA polymerase reveals mutations conferring resistance to chain termination.|pdf=|usr=}}
{{tp|p=34409594|t=2021. Genome-scale metabolic modelling of SARS-CoV-2 in cancer cells reveals an increased shift to glycolytic energy production.|pdf=|usr=}}
{{tp|p=34375459|t=2021. A glycosaminoglycan microarray identifies the binding of SARS-CoV-2 spike protein to chondroitin sulfate E.|pdf=|usr=}}
{{tp|p=34422917|t=2021. Clinical Implications of IL-32, IL-34 and IL-37 in Atherosclerosis: Speculative Role in Cardiovascular Manifestations of COVID-19.|pdf=|usr=}}
{{tp|p=34386533|t=2021. IL-10 and IL-12 (P70) Levels Predict the Risk of Covid-19 Progression in Hypertensive Patients: Insights From the BRACE-CORONA Trial.|pdf=|usr=}}
{{tp|p=34414185|t=2021. N439K Variant in Spike Protein Alter the Infection Efficiency and Antigenicity of SARS-CoV-2 Based on Molecular Dynamics Simulation.|pdf=|usr=}}
{{tp|p=34386498|t=2021. ORF3a-Mediated Incomplete Autophagy Facilitates Severe Acute Respiratory Syndrome Coronavirus-2 Replication.|pdf=|usr=}}
{{tp|p=34434902|t=2021. A Computational Approach to Evaluate the Combined Effect of SARS-CoV-2 RBD Mutations and ACE2 Receptor Genetic Variants on Infectivity: The COVID-19 Host-Pathogen Nexus.|pdf=|usr=}}
{{tp|p=34368076|t=2021. Identification of Potential Binding Sites of Sialic Acids on the RBD Domain of SARS-CoV-2 Spike Protein.|pdf=|usr=}}
{{tp|p=34394197|t=2021. poreCov-An Easy to Use, Fast, and Robust Workflow for SARS-CoV-2 Genome Reconstruction via Nanopore Sequencing.|pdf=|usr=}}
{{tp|p=34447386|t=2021. Update Advances on C-Reactive Protein in COVID-19 and Other Viral Infections.|pdf=|usr=}}
{{tp|p=34447375|t=2021. SARS-CoV-2 Proteome Harbors Peptides Which Are Able to Trigger Autoimmunity Responses: Implications for Infection, Vaccination, and Population Coverage.|pdf=|usr=}}
{{tp|p=34421894|t=2021. Antibody Response to SARS-CoV-2 Membrane Protein in Patients of the Acute and Convalescent Phase of COVID-19.|pdf=|usr=}}
{{tp|p=34408749|t=2021. Long Noncoding RNAs as Emerging Regulators of COVID-19.|pdf=|usr=}}
{{tp|p=34394120|t=2021. Transcriptome Analysis of Peripheral Blood Mononuclear Cells Reveals Distinct Immune Response in Asymptomatic and Re-Detectable Positive COVID-19 Patients.|pdf=|usr=}}
{{tp|p=34394108|t=2021. Identification of COVID-19 and Dengue Host Factor Interaction Networks Based on Integrative Bioinformatics Analyses.|pdf=|usr=}}
{{tp|p=34394094|t=2021. Single-Cell Transcriptomic Profiling of MAIT Cells in Patients With COVID-19.|pdf=|usr=}}
{{tp|p=34394090|t=2021. CD169 Defines Activated CD14(+) Monocytes With Enhanced CD8(+) T Cell Activation Capacity.|pdf=|usr=}}
{{tp|p=34386006|t=2021. Antibody Mediated Immunity to SARS-CoV-2 and Human Coronaviruses: Multiplex Beads Assay and Volumetric Absorptive Microsampling to Generate Immune Repertoire Cartography.|pdf=|usr=}}
{{tp|p=34367190|t=2021. Monocytes and Macrophages in COVID-19.|pdf=|usr=}}
{{tp|p=34367154|t=2021. Gene Expression Meta-Analysis Reveals Interferon-Induced Genes Associated With SARS Infection in Lungs.|pdf=|usr=}}
{{tp|p=34354712|t=2021. Dynamic Characteristic Analysis of Antibodies in Patients With COVID-19: A 13-Month Study.|pdf=|usr=}}
{{tp|p=34341659|t=2021. Severe COVID-19 Is Characterized by an Impaired Type I Interferon Response and Elevated Levels of Arginase Producing Granulocytic Myeloid Derived Suppressor Cells.|pdf=|usr=}}
{{tp|p=34335624|t=2021. Persistent Systemic Microbial Translocation and Intestinal Damage During Coronavirus Disease-19.|pdf=|usr=}}
{{tp|p=34335605|t=2021. High-Density Blood Transcriptomics Reveals Precision Immune Signatures of SARS-CoV-2 Infection in Hospitalized Individuals.|pdf=|usr=}}
{{tp|p=34335604|t=2021. The Pathogenic Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Possible Mechanisms for Immune Evasion?|pdf=|usr=}}
{{tp|p=34335596|t=2021. Immunopathogenesis of Different Emerging Viral Infections: Evasion, Fatal Mechanism, and Prevention.|pdf=|usr=}}
{{tp|p=34458281|t=2021. Gut Microbiota Dysbiosis Is a Crucial Player for the Poor Outcomes for COVID-19 in Elderly, Diabetic and Hypertensive Patients.|pdf=|usr=}}
{{tp|p=34434945|t=2021. Role of Th22 Cells in Human Viral Diseases.|pdf=|usr=}}
{{tp|p=34414199|t=2021. Downregulation of CD45 Signaling in COVID-19 Patients Is Reversed by C24D, a Novel CD45 Targeting Peptide.|pdf=|usr=}}
{{tp|p=34336891|t=2021. Antibodies Can Last for More Than 1 Year After SARS-CoV-2 Infection: A Follow-Up Study From Survivors of COVID-19.|pdf=|usr=}}
{{tp|p=34394051|t=2021. Genomic Surveillance and Phylodynamic Analyses Reveal the Emergence of Novel Mutations and Co-mutation Patterns Within SARS-CoV-2 Variants Prevalent in India.|pdf=|usr=}}
{{tp|p=34394024|t=2021. Profiling of Oral Microbiota and Cytokines in COVID-19 Patients.|pdf=|usr=}}
{{tp|p=34367091|t=2021. Hypoxia: The "Invisible Pusher" of Gut Microbiota.|pdf=|usr=}}
{{tp|p=34335535|t=2021. Mutations in SARS-CoV-2 ORF8 Altered the Bonding Network With Interferon Regulatory Factor 3 to Evade Host Immune System.|pdf=|usr=}}
{{tp|p=34335530|t=2021. Comprehensive Deep Mutational Scanning Reveals the Immune-Escaping Hotspots of SARS-CoV-2 Receptor-Binding Domain Targeting Neutralizing Antibodies.|pdf=|usr=}}
{{tp|p=34335504|t=2021. Coronavirus, the King Who Wanted More Than a Crown: From Common to the Highly Pathogenic SARS-CoV-2, Is the Key in the Accessory Genes?|pdf=|usr=}}
{{tp|p=34386518|t=2021. Non-RBM Mutations Impaired SARS-CoV-2 Spike Protein Regulated to the ACE2 Receptor Based on Molecular Dynamic Simulation.|pdf=|usr=}}
{{tp|p=34355020|t=2021. A Validated Mathematical Model of the Cytokine Release Syndrome in Severe COVID-19.|pdf=|usr=}}
{{tp|p=34354952|t=2021. Case Report: Discovery a Novel SARS-CoV-2 Variant in a Six-Months Long-Term Swab Positive Female Suffering From Non-Hodgkin Lymphoma.|pdf=|usr=}}
{{tp|p=34434905|t=2021. Acute Kidney Injury in Pediatric Acute SARS-CoV-2 Infection and Multisystem Inflammatory Syndrome in Children (MIS-C): Is There a Difference?|pdf=|usr=}}
{{tp|p=34422717|t=2021. Case Report: Mitral Valve Involvement and First-Degree Atrial-Ventricular Block in Two Patients With Multisystem Inflammatory Syndrome in Children.|pdf=|usr=}}
{{tp|p=34368030|t=2021. Case Report: Changes in Cytokine Kinetics During the Course of Disease in a Japanese Patient With Multisystem Inflammatory Syndrome in Children.|pdf=|usr=}}
{{tp|p=34421600|t=2021. NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments.|pdf=|usr=}}
{{tp|p=34335279|t=2021. The Role of High-Density Lipoprotein in COVID-19.|pdf=|usr=}}
{{tp|p=34413782|t=2021. Rarely Recognized Antibody Diversification in Covid-19 Evolution to Counteract Advanced SARS-CoV-2 Evasion Strategies, and Implications for Prophylactic Treatment.|pdf=|usr=}}
{{tp|p=34366882|t=2021. The Role of Innate Immunity and Bioactive Lipid Mediators in COVID-19 and Influenza.|pdf=|usr=}}
{{tp|p=34427676|t=2021. Potential Effect of Previous Human Coronavirus NL63 Infection on the Rate of Infection and the Clinical Course of Coronavirus Disease 2019.|pdf=|usr=}}
{{tp|p=34427670|t=2021. Critically ill COVID-19 patients exhibit hyperactive cytokine responses associated with effector exhausted senescent T cells in acute infection.|pdf=|usr=}}
{{tp|p=34427652|t=2021. SARS-CoV-2 infectivity correlates with high viral loads and detection of viral antigen and is terminated by seroconversion.|pdf=|usr=}}
{{tp|p=34423821|t=2021. Joint Estimation Of Generation Time And Incubation Period For Coronavirus Disease (Covid-19).|pdf=|usr=}}
{{tp|p=34409999|t=2021. SARS-CoV-2 variant Delta infects all 6 siblings but spares Comirnaty (BNT162b2, BioNTech/Pfizer)-vaccinated parents.|pdf=|usr=}}
{{tp|p=34343373|t=2021. Multisystem inflammatory syndrome in children during severe acute respiratory syndrome coronavirus-2 pandemic in Turkey: A single-centre experience.|pdf=|usr=}}
{{tp|p=34388280|t=2021. Neonatal Multisystem Inflammatory Syndrome secondary to SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=34409452|t=2021. Cluster characterization of SARS-CoV-2 in military personnel deployed to Egypt and subsequent introduction of B.1.1.7 and C.36 lineages to Colombia.|pdf=|usr=}}
{{tp|p=34452991|t=2021. Protease cleavage of RNF20 facilitates coronavirus replication via stabilization of SREBP1.|pdf=|usr=}}
{{tp|p=34433692|t=2021. Profound Treg perturbations correlate with COVID-19 severity.|pdf=|usr=}}
{{tp|p=34369011|t=2021. A distinct ssDNA/RNA binding interface in the Nsp9 protein from SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34375467|t=2021. Molecular dynamics analysis of a flexible loop at the binding interface of the SARS-CoV-2 spike protein receptor-binding domain.|pdf=|usr=}}
{{tp|p=34376481|t=2021. Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients.|pdf=|usr=}}
{{tp|p=34404118|t=2021. Natural infection of Delta mutant of SARS-CoV-2 in Asiatic lions of India.|pdf=|usr=}}
{{tp|p=34348612|t=2021. Role of potential COVID-19 immune system associated genes and the potential pathways linkage with type-2 diabetes.|pdf=|usr=}}
{{tp|p=34397331|t=2021. Low pH and temperature of airway surface liquid are key determinants that potentiate SARS-CoV-2 infectivity.|pdf=|usr=}}
{{tp|p=34417260|t=2021. SARS-CoV-2 Infection Drives a Glycan Switch of Peripheral T Cells at Diagnosis.|pdf=|usr=}}
{{tp|p=34389625|t=2021. Protracted yet Coordinated Differentiation of Long-Lived SARS-CoV-2-Specific CD8(+) T Cells during Convalescence.|pdf=|usr=}}
{{tp|p=34348975|t=2021. Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19.|pdf=|usr=}}
{{tp|p=34452933|t=2021. Suppressive Monocytes Impair MAIT Cells Response via IL-10 in Patients with Severe COVID-19.|pdf=|usr=}}
{{tp|p=34374752|t=2021. Distinct Mitochondria-Mediated T-Cell Apoptosis Responses in Children and Adults With Coronavirus Disease 2019.|pdf=|usr=}}
{{tp|p=34340303|t=2021. Why All the Fury over Furin?|pdf=|usr=}}
{{tp|p=34375002|t=2021. Viral proteins recognized by different TLRs.|pdf=|usr=}}
{{tp|p=34449894|t=2021. SARS-CoV-2 N-antigenemia in critically ill adult COVID-19 patients: Frequency and association with inflammatory and tissue-damage biomarkers.|pdf=|usr=}}
{{tp|p=34450642|t=2021. Rapid detection of neutralizing antibodies to SARS-CoV-2 variants in post-vaccination sera.|pdf=|usr=}}
{{tp|p=34459420|t=2021. Multisystem inflammatory syndrome with persistent neutropenia in neonate exposed to SARS-CoV-2 virus: A case report and review of literature.|pdf=|usr=}}
{{tp|p=34417772|t=2021. Bilateral Optic Disc Edema in Multisystem Inflammatory Syndrome in Children Associated With COVID-19.|pdf=|usr=}}
{{tp|p=34339544|t=2021. Comparison of clinical and laboratory profile of survivors and non-survivors of SARS-CoV-2-related multisystem inflammatory syndrome of childhood in India: An observational study.|pdf=|usr=}}
{{tp|p=34414434|t=2021. Updated Management Protocol for Multisystem Inflammatory Syndrome in Children (MIS-C).|pdf=|usr=}}
{{tp|p=34392371|t=2021. Mucocutaneous Findings of Multisystem Inflammatory Syndrome in Children: A Single-Center Experience.|pdf=|usr=}}
{{tp|p=34406361|t=2021. Confronting the Delta Variant of SARS-CoV-2, Summer 2021.|pdf=|usr=}}
{{tp|p=34383043|t=2021. Potential Implications of SARS-CoV-2 Delta Variant Surges for Rural Areas and Hospitals.|pdf=|usr=}}
{{tp|p=34387645|t=2021. Variants of SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34459875|t=2021. One-Year Outcomes of Critical Care Patients Post-COVID-19 Multisystem Inflammatory Syndrome in Children.|pdf=|usr=}}
{{tp|p=34341310|t=2021. Prevalence of COVID-19 genomic variation in Africa: a living systematic review protocol.|pdf=|usr=}}
{{tp|p=34331778|t=2021. Recurrent assessment of lymphocyte subsets in 32 patients with multisystem inflammatory syndrome in children (MIS-C).|pdf=|usr=}}
{{tp|p=34385349|t=2021. Deaths in Children and Adolescents Associated With COVID-19 and MIS-C in the United States.|pdf=|usr=}}
{{tp|p=34376480|t=2021. Immunophenotyping assessment in a COVID-19 cohort (IMPACC): A prospective longitudinal study.|pdf=|usr=}}
{{tp|p=34413221|t=2021. Do chronic infections breed dangerous new variants?|pdf=|usr=}}
{{tp|p=34413215|t=2021. Israel's grim warning: Delta can overwhelm shots.|pdf=|usr=}}
{{tp|p=34362872|t=2021. Phylogenomic analysis of SARS-CoV-2 from third wave clusters in Malaysia reveals dominant local lineage B.1.524 and persistent spike mutation A701V.|pdf=|usr=}}
{{tp|p=34363852|t=2021. Mutation hotspots and spatiotemporal distribution of SARS-CoV-2 lineages in Brazil, February 2020-2021.|pdf=|usr=}}
{{tp|p=34355546|t=2021. NLRP3 inflammasome activation and oxidative stress status in the mild and moderate SARS-CoV-2 infected patients: impact of melatonin as a medicinal supplement.|pdf=|usr=}}
{{tp|p=34428364|t=2021. Cytokine storm syndrome in SARS-CoV-2: a review.|pdf=|usr=}}

{{tp|p=34362671|t=2021. ORF8a as a viroporin in SARS-CoV-2 infection?|pdf=|usr=}}
{{tp|p=34425451|t=2021. SARS-CoV-2 N gene mutations impact detection by clinical molecular diagnostics: reports in two cities in the United States.|pdf=|usr=}}
{{tp|p=34410992|t=2021. Nine Cases of SARS-CoV-2-PCR-positive Samples Showed No Increase of Antibodies Against SARS-CoV-2.|pdf=|usr=}}
{{tp|p=34406867|t=2021. Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve In Vitro to Higher Infectivity through More Efficient Binding to Heparan Sulfate and Reduced S1/S2 Cleavage.|pdf=|usr=}}